Papillomaviruses and cancer: from basic studies to clinical application (scientific article (publication date: May 2002))

cites work (P2860)

Q38748275	"We've Been Together. We Don't Have It. We're Fine." How Relationship Status Impacts Human Papillomavirus Vaccine Behavior among Young Adult Women.
Q42217850	2011: the immune hallmarks of cancer
Q91966945	3'UTR polymorphism of Thymidylate Synthase gene increased the risk of persistence of pre-neoplastic cervical lesions
Q40651597	5-aza-2'-deoxycytidine (DAC) treatment downregulates the HPV E6 and E7 oncogene expression and blocks neoplastic growth of HPV-associated cancer cells
Q40448813	A DNA recombination-based approach to eliminate papillomavirus infection.
Q42834417	A DNA vaccine constructed with human papillomavirus type 16 (HPV16) E7 and E6 genes induced specific immune responses
Q36074627	A Meta-Analysis and Systematic Review on the Association between Human Papillomavirus (Types 16 and 18) Infection and Esophageal Cancer Worldwide
Q37644553	A catalyst for change: the European cancer Patient's Bill of Rights
Q33626382	A central region in the minor capsid protein of papillomaviruses facilitates viral genome tethering and membrane penetration for mitotic nuclear entry
Q41430933	A comparative study of three different nucleic acid amplification techniques combined with microchip electrophoresis for HPV16 E6/E7 mRNA detection
Q35169110	A comparison of clinically utilized human papillomavirus detection methods in head and neck cancer
Q35088658	A competitive serological assay shows naturally acquired immunity to human papillomavirus infections in the Guanacaste Natural History Study
Q33747434	A comprehensive evaluation of the accuracy of cervical pre-cancer detection methods in a high-risk area in East Congo
Q53184803	A critical role of MYC for transformation of human cells by HPV16 E6E7 and oncogenic HRAS.
Q30789709	A downstream polyadenylation element in human papillomavirus type 16 L2 encodes multiple GGG motifs and interacts with hnRNP H.
Q28943277	A genome-wide association study identifies two new cervical cancer susceptibility loci at 4q12 and 17q12
Q38728023	A new marker, insulinoma-associated protein 1 (INSM1), for high-grade neuroendocrine carcinoma of the uterine cervix: Analysis of 37 cases
Q39240273	A novel mechanism of rs763110 polymorphism contributing to cervical cancer risk by affecting the binding affinity of C/EBPβ and OCT1 complex to chromatin
Q30855284	A novel peptide motif binding to and blocking the intracellular activity of the human papillomavirus E6 oncoprotein
Q80593643	A novel rodent papillomavirus isolated from anogenital lesions in its natural host
Q50977752	A novel self-assembled nanoparticle vaccine with HIV-1 Tat₄₉₋₅₇/HPV16 E7₄₉₋₅₇ fusion peptide and GM-CSF DNA elicits potent and prolonged CD8⁺ T cell-dependent anti-tumor immunity in mice.
Q43601291	A novel, broad spectrum therapeutic HPV vaccine targeting the E7 proteins of HPV16, 18, 31, 45 and 52 that elicits potent E7-specific CD8T cell immunity and regression of large, established, E7-expressing TC-1 tumors
Q64239416	A pap-smear analysis tool (PAT) for detection of cervical cancer from pap-smear images
Q84177291	A pilot study to investigate the treatment of cervical human papillomavirus infection with zinc-citrate compound (CIZAR®)
Q33793914	A population-based prospective study of carcinogenic human papillomavirus variant lineages, viral persistence, and cervical neoplasia
Q33608013	A portrait of single and multiple HPV type infections in Brazilian women of different age strata with squamous or glandular cervical lesions
Q35537981	A quantum dots and superparamagnetic nanoparticle-based method for the detection of HPV DNA.
Q37334258	A quest for initiating cells of head and neck cancer and their treatment
Q54668976	A region on human chromosome 4 (q35.1-->qter) induces senescence in cell hybrids and is involved in cervical carcinogenesis.
Q39012420	A retinoblastoma allele that is mutated at its common E2F interaction site inhibits cell proliferation in gene-targeted mice
Q35426521	A retrospective investigation on canine papillomavirus 1 (CPV1) in oral oncogenesis reveals dogs are not a suitable animal model for high-risk HPV-induced oral cancer
Q38093213	A review of dietary prevention of human papillomavirus-related infection of the cervix and cervical intraepithelial neoplasia.
Q26741909	A review of the infection-associated cancers in North African countries
Q33766992	A role for HPV16 E5 in cervical carcinogenesis
Q35019191	A role for microRNA-155 expression in microenvironment associated to HPV-induced carcinogenesis in K14-HPV16 transgenic mice
Q38450854	A subset of head and neck squamous cell carcinomas exhibits integration of HPV 16/18 DNA and overexpression of p16INK4A and p53 in the absence of mutations in p53 exons 5–8
Q33679518	A systematic investigation of the association between HPV and the clinicopathological parameters and prognosis of oral and oropharyngeal squamous cell carcinomas.
Q41524569	A systematic investigation of the contribution of genetic variation within the MHC region to HPV seropositivity
Q34461031	A systems biology analysis of the changes in gene expression via silencing of HPV-18 E1 expression in HeLa cells
Q45218505	A tale of three Hs: HPV, HIV & HAART.
Q60921936	A therapeutic vaccine targeting HPV E6/E7 with intrinsic Toll-like receptor 2 agonist activity induces antitumor immunity
Q39253672	A transmembrane domain and GxxxG motifs within L2 are essential for papillomavirus infection
Q92369502	A virome-wide clonal integration analysis platform for discovering cancer viral etiology
Q37547486	APOBEC3 deaminases induce hypermutation in human papillomavirus 16 DNA upon beta interferon stimulation.
Q38742812	APOBEC3A associates with human papillomavirus genome integration in oropharyngeal cancers.
Q36046161	APOBEC3A possesses anticancer and antiviral effects by differential inhibition of HPV E6 and E7 expression on cervical cancer
Q34321805	Aberrant expression and constitutive activation of STAT3 in cervical carcinogenesis: implications in high-risk human papillomavirus infection
Q35769502	Aberrant expression of VEGF-C is related to grade of cervical intraepithelial neoplasia (CIN) and high risk HPV, but does not predict virus clearance after treatment of CIN or prognosis of cervical cancer.
Q39536282	Aberrant expression of disintegrin-metalloprotease proteins in the formation and progression of uterine cervical cancer
Q53281416	Aberrant promoter methylation and loss of suppressor of cytokine signalling-1 gene expression in the development of uterine cervical carcinogenesis.
Q97524272	Aberrant promoter methylation of NOTCH1 and NOTCH3 and its association with cervical cancer risk factors in North Indian population
Q33558774	Abrogation of the Brd4-positive transcription elongation factor B complex by papillomavirus E2 protein contributes to viral oncogene repression
Q37110741	Abrogation of the postmitotic checkpoint contributes to polyploidization in human papillomavirus E7-expressing cells
Q42146528	Acetylation of intragenic histones on HPV16 correlates with enhanced HPV16 gene expression
Q36241639	Acquisition of high-risk human papillomavirus infections and pap smear abnormalities among women in the New Independent States of the Former Soviet Union
Q35020680	Activated Notch1 inhibits p53-induced apoptosis and sustains transformation by human papillomavirus type 16 E6 and E7 oncogenes through a PI3K-PKB/Akt-dependent pathway
Q33800021	Activating transcription factor 3 activates p53 by preventing E6-associated protein from binding to E6.
Q38902030	Activation of G-protein coupled estrogen receptor inhibits the proliferation of cervical cancer cells via sustained activation of ERK1/2.
Q34956555	Activation of miR-9 by human papillomavirus in cervical cancer.
Q39735079	Activities of E7 promoters in the human papillomavirus type 16 genome during cell differentiation
Q38891470	Activity of Andrographolide and Its Derivatives on HPV16 Pseudovirus Infection and Viral Oncogene Expression in Cervical Carcinoma Cells
Q88977347	Adenosine causes read-through into the late region of the HPV16 genome in a guanosine-dependent manner
Q33386408	Adenovirus E4orf4 induces HPV-16 late L1 mRNA production
Q59329445	Advances in Designing and Developing Vaccines, Drugs and Therapeutic Approaches to Counter Human Papilloma Virus
Q36773460	Advances in primary and secondary interventions for cervical cancer: human papillomavirus prophylactic vaccines and testing
Q56766086	Advancing rapid point-of-care viral diagnostics to a clinical setting
Q50065081	Aetiological heterogeneity of head and neck squamous cell carcinomas: the role of human papillomavirus infections, smoking and alcohol
Q44562266	AgNOR technique could be useful for differential diagnosis of squamous carcinomatous cells and atypical cells related to human papillomavirus in cervical smears
Q44330271	AgNOR, p16 and human papillomavirus in low-grade squamous intra-epithelial lesions of the uterine cervix. Preliminary report
Q61705515	Age factor and implication of human papillomavirus type-specific prevalence in women with normal cervical cytology
Q40213398	Alpha- and betapapillomavirus E6/E7 genes differentially modulate pro-inflammatory gene expression
Q34127590	Alteration of microRNA profiles in squamous cell carcinoma of the head and neck cell lines by human papillomavirus
Q54691502	Altered patterns of the interferon-inducible gene IFI16 expression in head and neck squamous cell carcinoma: immunohistochemical study including correlation with retinoblastoma protein, human papillomavirus infection and proliferation index.
Q33859710	Alternative splicing of human papillomavirus type-16 E6/E6* early mRNA is coupled to EGF signaling via Erk1/2 activation
Q33260497	Alternative technologies in cervical cancer screening: a randomised evaluation trial
Q92635557	An Effective Primary Head and Neck Squamous Cell Carcinoma In Vitro Model
Q31121276	An enhanced heterologous virus-like particle for human papillomavirus type 16 tumour immunotherapy
Q42600424	An epidermotropic canine papillomavirus with malignant potential contains an E5 gene and establishes a unique genus
Q50919041	An evaluation of the diagnostic and prognostic significance of p16(INK4a) /p21(WAF1/Cip1) immunostaining in squamous intraepithelial lesions of the uterine cervix using liquid-based cytology specimens.
Q40229618	An improved method for primary culture of normal cervical epithelial cells and establishment of cell model in vitro with HPV-16 E6 gene by lentivirus
Q38088850	An update review on HPV testing methods for cervical neoplasia
Q27014019	An updated overview of HPV-associated head and neck carcinomas
Q33769367	Anal HPV infection in HIV-positive men who have sex with men from China
Q36768964	Anal Neoplasia in Inflammatory Bowel Disease Is Associated With HPV and Perianal Disease
Q36224974	Analysis of Sequence Variation and Risk Association of Human Papillomavirus 52 Variants Circulating in Korea.
Q34673597	Analysis of cytosine-adenine repeats in P1 promoter region of IGF-1 gene in peripheral blood cells and cervical tissue samples of females with cervical intraepithelial lesions and squamous cervical cancer
Q47110076	Analysis of human papilloma virus type 52 integration status in exfoliated cervical cells
Q92715645	Analysis of human papillomavirus 16 E6/E7 and L1 in the bronchial brushing cells of patients with squamous cell carcinoma of the lungs
Q40877734	Analysis of human papillomavirus 16 variants and risk for cervical cancer in Chinese population
Q38946815	Analysis of human papillomavirus E7 protein status in C-33A cervical cancer cells.
Q34953460	Analysis of mutations in the E6 oncogene of human papillomavirus 16 in cervical cancer isolates from Moroccan women
Q36295157	Analysis of novel human papillomavirus type 16 late mRNAs in differentiated W12 cervical epithelial cells
Q36623467	Analysis of the coding sequence and expression of the coiled-coil α-helical rod protein 1 gene in normal and neoplastic epithelial cervical cells
Q34568682	Analysis of the roles of E6 binding to E6TP1 and nuclear localization in the human papillomavirus type 31 life cycle
Q55424301	Ancient DNA provides evidence of 27,000-year-old papillomavirus infection and long-term codivergence with rodents.
Q44073918	Ancillary testing of liquid-based cytology specimens for identification of patients at high risk of cervical cancer
Q37466363	Annual disease burden due to human papillomavirus (HPV) 6 and 11 infections in Finland
Q39926013	Annual disease burden due to human papillomavirus 16 and 18 infections in Finland
Q64994840	Anti-tumor effect of aloe-emodin on cervical cancer cells was associated with human papillomavirus E6/E7 and glucose metabolism.
Q35887186	Anti-tumor effects of genetic vaccines against HPV major oncogenes
Q39014551	Anti-tumour activity of a novel coumarin-chalcone hybrid is mediated through intrinsic apoptotic pathway by inducing PUMA and altering Bax/Bcl-2 ratio
Q50986341	Anticancer activity of Phyllanthus emblica Linn. (Indian gooseberry): inhibition of transcription factor AP-1 and HPV gene expression in cervical cancer cells.
Q34190322	Anticancer property of Bryophyllum pinnata (Lam.) Oken. leaf on human cervical cancer cells
Q27488697	Antigen-specific immunotherapy of cervical and ovarian cancer
Q33288535	Antisense targeting human papillomavirus type 16 E6 and E7 genes contributes to apoptosis and senescence in SiHa cervical carcinoma cells
Q45705136	Antitumor efficacy of Venezuelan equine encephalitis virus replicon particles encoding mutated HPV16 E6 and E7 genes
Q33327764	Apoptosis induction in Jurkat cells and sCD95 levels in women's sera are related with the risk of developing cervical cancer
Q34017838	Apoptosis inhibitor-5 overexpression is associated with tumor progression and poor prognosis in patients with cervical cancer
Q34264940	Apoptotic HPV positive cancer cells exhibit transforming properties
Q26783442	Application Progress of CRISPR/Cas9 System for Gene Editing in Tumor Research
Q36232683	Applications of major histocompatibility complex class I molecules expressed as single chains
Q38653658	Applications of molecular diagnostics for personalized treatment of head and neck cancer: state of the art.
Q38216925	Are human polyomaviruses co-factors for cancers induced by other oncoviruses?
Q81298973	Are transforming properties of the bovine papillomavirus E5 protein shared by E5 from high-risk human papillomavirus type 16?
Q39182083	Argentophilic nucleolus organizer region as a proliferation marker in cervical intraepithelial neoplasia grade 1 of the uterine cervix
Q38891941	Assessment of the incidence of squamous cell papilloma of the esophagus and the presence of high-risk human papilloma virus
Q44169844	Association Between Serum Cytokine Profiles and Clearance or Persistence of High-Risk Human Papillomavirus Infection: A Prospective Study
Q35691927	Association Study between Cervical Lesions and Single or Multiple Vaccine-Target and Non-Vaccine Target Human Papillomavirus (HPV) Types in Women from Northeastern Brazil
Q38866747	Association between circulating interleukin-1 beta (IL-1β) levels and IL-1β C-511T polymorphism with cervical cancer risk in Egyptian women
Q34351591	Association between human papillomavirus DNA and temporal arteritis
Q35670508	Association between human papillomavirus and Epstein - Barr virus DNA and gene promoter methylation of RB1 and CDH1 in the cervical lesions: a transversal study
Q54224728	Association of CDKN2A polymorphisms with the severity of cervical neoplasia in a Brazilian population.
Q57918891	Association of XRCC1 Arg399Gln and OGG1 Ser326Cys polymorphisms with the risk of cervical cancer in Japanese subjects
Q49925064	Association of an intact E2 gene with higher HPV viral load, higher viral oncogene expression, and improved clinical outcome in HPV16 positive head and neck squamous cell carcinoma
Q28271164	Association of epigenetic inactivation of the WRN gene with anticancer drug sensitivity in cervical cancer cells
Q35154133	Association of human papillomavirus 16 E6 variants with cervical carcinoma and precursor lesions in women from Southern Mexico
Q38380216	Association of human papillomavirus with Fanconi anemia promotes carcinogenesis in Fanconi anemia patients
Q94146671	Association of long non-coding RNA HOTAIR and MALAT1 variants with cervical cancer risk in Han Chinese women
Q47251663	Association of papillomavirus E6 proteins with either MAML1 or E6AP clusters E6 proteins by structure, function, and evolutionary relatedness
Q24312129	Association of the human papillomavirus type 16 E7 oncoprotein with the 600-kDa retinoblastoma protein-associated factor, p600
Q37718258	Association of the miR-17-5p variants with susceptibility to cervical cancer in a Chinese population
Q88938307	Association of variants of miRNA processing genes with cervical precancerous lesion risk in a southern Chinese population
Q34283696	Associations between human papillomavirus and history of cancer among U.S. adults in the National Health and Nutrition Examination Survey (2003-2010)
Q39700431	Attribution of human papillomavirus types to cervical intraepithelial neoplasia and invasive cancers in Southern China
Q92937016	Autocrine STAT3 activation in HPV positive cervical cancer through a virus-driven Rac1-NFκB-IL-6 signalling axis
Q26784314	Autophagy knocked down by high-risk HPV infection and uterine cervical carcinogenesis
Q55056320	BIRC2 amplification in squamous cell carcinomas of the uterine cervix.
Q26798188	Bacterial Genotoxins: Merging the DNA Damage Response into Infection Biology
Q36933987	Bap31 is a novel target of the human papillomavirus E5 protein
Q35641828	Barriers to and facilitators of compliance with clinic-based cervical cancer screening: population-based cohort study of women aged 23-60 years
Q36529848	Basics of tumor development and importance of human papilloma virus (HPV) for head and neck cancer
Q35273769	Bead-based multiplex genotyping of 58 cutaneous human papillomavirus types.
Q34430808	Bead-based multiplex genotyping of human papillomaviruses
Q38445240	Betapapillomavirus in multiple non-melanoma skin cancers of Netherton syndrome: Case report and published work review
Q43688089	Bilateral squamous cell carcinoma of the feet associated with human papillomavirus type 16 infection
Q42700753	Binase treatment increases interferon sensitivity and apoptosis in SiHa cervical carcinoma cells by downregulating E6 and E7 human papilloma virus oncoproteins
Q83474648	Binding of PDZ proteins to HPV E6 proteins does neither correlate with epidemiological risk classification nor with the immortalization of foreskin keratinocytes
Q38702843	Bioinformatics and in vitro experimental analyses identify the selective therapeutic potential of interferon gamma and apigenin against cervical squamous cell carcinoma and adenocarcinoma
Q38025306	Biology of human papillomavirus infections in head and neck carcinogenesis.
Q37998530	Biomarkers for cervical cancer screening: the role of p16(INK4a) to highlight transforming HPV infections
Q42585009	Biophysical characterization of the complex between human papillomavirus E6 protein and synapse-associated protein 97.
Q53582850	Bmi-1 cooperates with human papillomavirus type 16 E6 to immortalize normal human oral keratinocytes.
Q28594481	Bovine papillomavirus E7 transformation function correlates with cellular p600 protein binding
Q40589902	Bovine papillomavirus replicative helicase E1 is a target of the ubiquitin ligase APC.
Q51875154	Bowen disease of the palm associated with human papillomavirus 52.
Q37566747	Brd4-mediated nuclear retention of the papillomavirus E2 protein contributes to its stabilization in host cells
Q53346807	Brushing of oral mucosa for diagnosis of HPV infection in patients with potentially malignant and malignant oral lesions.
Q53323834	CCND1 G870A polymorphism and cervical cancer risk: a case-control study and meta-analysis.
Q53286766	CCND1 rs9344 polymorphisms are associated with the genetic susceptibility to cervical cancer in Chinese population.
Q33600422	CCR2-V64I polymorphism is associated with increased risk of cervical cancer but not with HPV infection or pre-cancerous lesions in African women
Q52332737	CD1-Restricted T Cells During Persistent Virus Infections: "Sympathy for the Devil".
Q34296041	CD1d, a Sentinel Molecule Bridging Innate and Adaptive Immunity, Is Downregulated by the Human Papillomavirus (HPV) E5 Protein: a Possible Mechanism for Immune Evasion by HPV
Q45375334	CD4+ T cells against human papillomavirus-18 E7 in patients with high-grade cervical lesions associate with the absence of the virus in the cervix
Q35694739	CD4+ cell count and HIV load as predictors of size of anal warts over time in HIV-infected women.
Q54976448	CIP2A facilitates the G1/S cell cycle transition via B-Myb in human papillomavirus 16 oncoprotein E6-expressing cells.
Q47553089	CRISPR-Cas Targeting of Host Genes as an Antiviral Strategy
Q49477344	CRISPR-Cas9: a promising genetic engineering approach in cancer research
Q54393798	Can 'high-risk' human papillomaviruses (HPVs) be detected in human breast milk?
Q37307199	Cancer biomarkers: are we ready for the prime time?
Q55472478	Cancer immunoprevention: from mice to early clinical trials.
Q35230184	Cancer immunotherapy using a DNA vaccine encoding a single-chain trimer of MHC class I linked to an HPV-16 E6 immunodominant CTL epitope
Q28607775	Capsid display of a conserved human papillomavirus L2 peptide in the adenovirus 5 hexon protein: a candidate prophylactic hpv vaccine approach
Q28743261	Capsomer vaccines protect mice from vaginal challenge with human papillomavirus
Q36997120	Carbohydrates and cancer: an overview of the epidemiological evidence
Q34543781	Carbonic anhydrase IX (CA-IX) and high-risk human papillomavirus (H-HPV) as diagnostic biomarkers of cervical dysplasia/neoplasia in Japanese women with a cytologic diagnosis of atypical glandular cells (AGC): a Gynecologic Oncology Group (GOG) Stud
Q64065617	Carboplatin/paclitaxel, E7-vaccination and intravaginal CpG as tri-therapy towards efficient regression of genital HPV16 tumors
Q36594207	Casein kinase II motif-dependent phosphorylation of human papillomavirus E7 protein promotes p130 degradation and S-phase induction in differentiated human keratinocytes
Q38731807	Cdc6 expression is induced by HPV16 E6 and E7 oncogenes and represses E-cadherin expression.
Q33269437	Cell cycle progression and de novo centriole assembly after centrosomal removal in untransformed human cells
Q42285472	Cell cycle suppressor proteins are not related to HPV status or clinical outcome in patients with vulvar carcinoma
Q40280232	Cell cycle-controlled interaction of nucleolin with the retinoblastoma protein and cancerous cell transformation
Q47129762	Cell death and restoration of TRAIL-sensitivity by ciglitazone in resistant cervical cancer cells
Q39180977	Cell growth inhibition in HPV 18 positive uveal melanoma cells by E6/E7 siRNA.
Q42031235	Cell-restricted immortalization by human papillomavirus correlates with telomerase activation and engagement of the hTERT promoter by Myc.
Q37350422	Cellular and molecular biological aspects of cervical intraepithelial neoplasia
Q36989890	Cellular transformation by human papillomaviruses: lessons learned by comparing high- and low-risk viruses
Q35841813	Centrosome abnormalities during a Chlamydia trachomatis infection are caused by dysregulation of the normal duplication pathway
Q37424993	Centrosome overduplication, chromosomal instability, and human papillomavirus oncoproteins
Q37307576	Cervarix: a vaccine for the prevention of HPV 16, 18-associated cervical cancer.
Q33806351	Cervical Cancer Neoantigen Landscape and Immune Activity is Associated with Human Papillomavirus Master Regulators
Q36735294	Cervical Cancer Screening for the Reluctant - HPV Testing of Air-Dried Vaginal Discharge
Q37579334	Cervical Cancer: Development of Targeted Therapies Beyond Molecular Pathogenesis
Q89390019	Cervical cancer screening among transactional female sex workers in the Dominican Republic
Q35592340	Cervical cancer screening and treatment of cervical intraepithelial neoplasia in female sex workers using "screen and treat" approach.
Q36170110	Cervical cancers require the continuous expression of the human papillomavirus type 16 E7 oncoprotein even in the presence of the viral E6 oncoprotein
Q54657667	Cervical intraepithelial neoplasia: Telomerase activity and splice pattern of hTERT mRNA
Q42479703	Cervical nitric oxide release and persistence of high-risk human papillomavirus in women
Q53072274	Changes in HPV Knowledge Among College Women from 2008 to 2015.
Q36849676	Changing the paradigm: the potential for targeted therapy in laryngeal squamous cell carcinoma
Q35613632	Characterization of NOL7 gene point mutations, promoter methylation, and protein expression in cervical cancer
Q35626510	Characterization of Single-Nucleotide Polymorphisms in the Tumor Necrosis Factor α Promoter Region and in Lymphotoxin α in Squamous Intraepithelial Lesions, Precursors of Cervical Cancer
Q34171663	Characterization of an RNA aptamer against HPV-16 L1 virus-like particles
Q33271188	Characterization of antibodies in single-chain format against the E7 oncoprotein of the human papillomavirus type 16 and their improvement by mutagenesis.
Q91583897	Characterization of cervical biopsies of women with HIV and HPV co-infection using p16ink4a, ki-67 and HPV E4 immunohistochemistry and DNA methylation
Q37582845	Characterization of human papillomavirus type 154 and tissue tropism of gammapapillomaviruses
Q35115646	Characterization of novel transcripts of human papillomavirus type 16 using cap analysis gene expression technology
Q37093527	Characterization of p16 and E6 HPV-related proteins in uterine cervix high-grade lesions of patients treated by conization with large loop excision
Q41253282	Characterization of the Human Papillomavirus 16 E8 Promoter.
Q37997368	Characterization of the human papillomavirus (HPV) integration sites into genital cancers
Q34813512	Characterization of the methylation patterns in human papillomavirus type 16 viral DNA in head and neck cancers
Q38940518	Chemo-immunotherapy using saffron and its ingredients followed by E7-NT (gp96) DNA vaccine generates different anti-tumor effects against tumors expressing the E7 protein of human papillomavirus.
Q36967911	Chimeric HBcAg virus-like particles presenting a HPV 16 E7 epitope significantly suppressed tumor progression through preventive or therapeutic immunization in a TC-1-grafted mouse model
Q34545451	Chlamydia induces anchorage independence in 3T3 cells and detrimental cytological defects in an infection model
Q45126102	Chromosome stability in tonsillar squamous cell carcinoma is associated with HPV16 integration and indicates a favorable prognosis
Q37565121	Cidofovir is active against human papillomavirus positive and negative head and neck and cervical tumor cells by causing DNA damage as one of its working mechanisms
Q34736407	Cidofovir selectivity is based on the different response of normal and cancer cells to DNA damage
Q89574572	Circulating HPV cDNA in the blood as a reliable biomarker for cervical cancer: A meta-analysis
Q37456554	Circulating human papillomavirus DNA detected using droplet digital PCR in the serum of patients diagnosed with early stage human papillomavirus-associated invasive carcinoma
Q29618731	Classification of papillomaviruses
Q36404806	Clinical Utility of Molecular Biomarkers in Cervical Squamous Intraepithelial Lesions in a Young Adult Population
Q24805521	Clinical and biological characteristics of cervical neoplasias with FGFR3 mutation
Q34031281	Clinical and scientific impact of human papillomavirus on head and neck cancer
Q51018979	Clinical outcome of stage Ia1 squamous cell carcinoma of the uterine cervix and pathological findings of initial conization.
Q37451826	Clinical performance of human papillomavirus E6 and E7 mRNA testing for high-grade lesions of the cervix.
Q41260329	Clinical performance of multiplex high-risk e6 mrna expression in comparison with hpv dna subtypes for the identification of women at risk of cervical cancer
Q87690487	Clinical significance of Wnt-11 and squamous cell carcinoma antigen expression in cervical cancer
Q54740040	Clinical significance of hTERC gene amplification detection by FISH in the screening of cervical lesions.
Q39827884	Clinical significance of matrix metalloproteinase-2 in cancer of uterine cervix: a semiquantitative study of immunoreactivities using tissue array.
Q35697392	Clinicopathological characteristics of esophageal squamous papillomas in Japanese patients--with comparison of findings from Western countries
Q51872903	Clinicopathological findings of canine seborrhoeic keratosis with comparison to pigmented viral plaques.
Q38439713	Clonal history of papillomavirus-induced dysplasia in the female lower genital tract
Q89456444	Co-Infection of Human Papillomavirus with Mycoplasma Hominis/Ureaplasma Urealyticum Among Female Sex Workers in Medan, Indonesia
Q39796145	Coadministration of the fungal immunomodulatory protein FIP-Fve and a tumour-associated antigen enhanced antitumour immunity
Q38691038	Codon Usage Optimization and Construction of Plasmid Encoding Iranian Human Papillomavirus Type 16 E7 Oncogene for Lactococcus Lactis Subsp. Cremoris MG1363
Q40238348	Cohort Profile: African Collaborative Center for Microbiome and Genomics Research's (ACCME) Human Papillomavirus (HPV) and Cervical Cancer Study
Q38792909	Coinjection of IL2 DNA enhances E7-specific antitumor immunity elicited by intravaginal therapeutic HPV DNA vaccination with electroporation
Q34681507	Colorectal papillomavirus infection in patients with colorectal cancer
Q37271700	Combination of proteasome and HDAC inhibitors for uterine cervical cancer treatment
Q37038302	Combination of treatment with death receptor 5-specific antibody with therapeutic HPV DNA vaccination generates enhanced therapeutic anti-tumor effects
Q55038958	Combined Extensive Esophageal Squamous Papillomas and Florid Cardiac Gland Hyperplasia in a Patient with Adenocarcinoma.
Q90831560	Combined assessment of 3q26 amplification and promoter methylation in patients with high grade cervical lesions show age specific differences
Q36582348	Commentary: nm23, a metastasis suppressor gene with a tumor suppressor gene aptitude?
Q40473479	Common fragile sites (CFS) and extremely large CFS genes are targets for human papillomavirus integrations and chromosome rearrangements in oropharyngeal squamous cell carcinoma.
Q33798276	Comparative analysis of HPV16 gene expression profiles in cervical and in oropharyngeal squamous cell carcinoma
Q37516596	Comparative effectiveness study on human papillomavirus detection methods used in the cervical cancer screening programme
Q39222826	Comparative transforming potential of different human papillomaviruses associated with non-melanoma skin cancer
Q54277497	Comparison of oncogenic HPV type-specific viral DNA load and E6/E7 mRNA detection in cervical samples: results from a multicenter study.
Q35943033	Comparison of the GenoFlow human papillomavirus (HPV) test and the Linear Array assay for HPV screening in an Asian population.
Q33587856	Comparison of the performance of carcinogenic HPV typing of the Roche Linear Array and Qiagen LiquiChip® HPV assays
Q33843034	Complementation of human papillomavirus type 16 E6 and E7 by Jagged1-specific Notch1-phosphatidylinositol 3-kinase signaling involves pleiotropic oncogenic functions independent of CBF1;Su(H);Lag-1 activation.
Q51767021	Comprehensive analysis of 130 multicentric intraepithelial female lower genital tract lesions by HPV typing and p16 expression profile.
Q55007219	Computational identification, characterization and validation of potential antigenic peptide vaccines from hrHPVs E6 proteins using immunoinformatics and computational systems biology approaches.
Q35634408	Concordance analysis of methylation biomarkers detection in self-collected and physician-collected samples in cervical neoplasm
Q41497995	Conditionally activated E7 proteins of high-risk and low-risk human papillomaviruses induce S phase in postmitotic, differentiated human keratinocytes
Q37596549	Conserved methylation patterns of human papillomavirus type 16 DNA in asymptomatic infection and cervical neoplasia
Q38440216	Contribution of gross chromosomal changes to HPV16-induced transformation
Q36383234	Contribution of retinoblastoma LOH and the p53 Arg/Pro polymorphism to cervical cancer
Q37277545	Control of alpha subunit of eukaryotic translation initiation factor 2 (eIF2 alpha) phosphorylation by the human papillomavirus type 18 E6 oncoprotein: implications for eIF2 alpha-dependent gene expression and cell death
Q90714962	Cooperation of genes in HPV16 E6/E7-dependent cervico-vaginal carcinogenesis trackable by endoscopy and independent of exogenous estrogens or carcinogens
Q33675027	Correlates of cervicovaginal human papillomavirus detection in perimenopausal women.
Q92309247	Correlation between Common Lower Genital Tract Microbes and High-Risk Human Papillomavirus Infection
Q34033823	Correlation between ELISA and pseudovirion-based neutralisation assay for detecting antibodies against human papillomavirus acquired by natural infection or by vaccination
Q37159889	Correlation between ebv co-infection and HPV16 genome integrity in Tunisian cervical cancer patients
Q37767665	Correlation between hybrid capture II high-risk human papillomavirus DNA test chemiluminescence intensity from cervical samples with follow-up histologic results: a cytologic/histologic review of 367 cases
Q48966344	Correlation between indoleamine 2,3 dioxygenase mRNA and CDKN2A/p16 mRNA: a combined strategy to cervical cancer diagnosis
Q36014230	Correlation between laminin-5 immunohistochemistry and human papillomavirus status in squamous cervical carcinoma.
Q37717281	Correlation of EGFR, pEGFR and p16INK4 expressions and high risk HPV infection in HIV/AIDS-related squamous cell carcinoma of conjunctiva
Q54365683	Correlation of LAPTM4B polymorphisms with cervical carcinoma.
Q46386588	Correlation of Twist upregulation and senescence bypass during the progression and metastasis of cervical cancer
Q34473420	Cottontail rabbit papillomavirus (CRPV) model system to test antiviral and immunotherapeutic strategies
Q34499114	Could JC virus provoke metastasis in colon cancer?
Q51007196	Could the human papillomavirus vaccines drive virulence evolution?
Q37291242	Cross-talk between Human Papillomavirus Oncoproteins and Hedgehog Signaling Synergistically Promotes Stemness in Cervical Cancer Cells
Q59813521	Crosstalk Between PD-1/PD-L1 Blockade and Its Combinatorial Therapies in Tumor Immune Microenvironment: A Focus on HNSCC
Q48409281	Curcumin as an anti-human papillomavirus and anti-cancer compound
Q35531894	Curcumin modulates cellular AP-1, NF-kB, and HPV16 E6 proteins in oral cancer.
Q54402654	Curcumin suppresses human papillomavirus oncoproteins, restores p53, rb, and ptpn13 proteins and inhibits benzo[a]pyrene‐induced upregulation of HPV E7
Q39191687	Current and Emerging Molecular Tests for Human Papillomavirus-Related Neoplasia in the Genomic Era.
Q38743922	Current state in the development of candidate therapeutic HPV vaccines
Q37135023	Current therapeutic vaccination and immunotherapy strategies for HPV-related diseases.
Q30196669	Current views and advances on Paediatric Virology: An update for paediatric trainees
Q36419678	Current views on the role of human papillomaviruses in cutaneous oncogenesis
Q34081681	Cutaneous HPV23 E6 prevents p53 phosphorylation through interaction with HIPK2.
Q55054189	Cutaneous Papillomaviruses and Non-melanoma Skin Cancer: Causal Agents or Innocent Bystanders?
Q21245129	Cutaneous and mucosal human papillomaviruses differ in net surface charge, potential impact on tropism
Q39972408	Cutaneous human papillomavirus in head and neck squamous cell carcinomas
Q34537702	Cyclin A1 promoter hypermethylation in human papillomavirus-associated cervical cancer
Q35784867	Cytotoxic T-lymphocyte responses to human papillomavirus type 16 E5 and E7 proteins and HLA-A*0201-restricted T-cell peptides in cervical cancer patients
Q39166828	DDX3 loss by p53 inactivation promotes tumor malignancy via the MDM2/Slug/E-cadherin pathway and poor patient outcome in non-small-cell lung cancer
Q37269248	DEPTOR promotes survival of cervical squamous cell carcinoma cells and its silencing induces apoptosis through downregulating PI3K/AKT and by up-regulating p38 MAP kinase
Q39046294	DLG1 polarity protein expression associates with the disease progress of low-grade cervical intraepithelial lesions
Q35931316	DNA Copy Number Aberrations, and Human Papillomavirus Status in Penile Carcinoma. Clinico-Pathological Correlations and Potential Driver Genes
Q37724792	DNA damage response is hijacked by human papillomaviruses to complete their life cycle
Q49890881	DNA methylation regulated microRNAs in HPV-16-induced head and neck squamous cell carcinoma (HNSCC).
Q39764670	DNA vaccine against human papillomavirus type 16: modifications of the E6 oncogene
Q79713037	DNA vaccine encoding endosome-targeted human papillomavirus type 16 E7 protein generates CD4+ T cell-dependent protection
Q36316734	DNA vaccines encoding IL-2 linked to HPV-16 E7 antigen generate enhanced E7-specific CTL responses and antitumor activity
Q33680693	DNA vaccines for cervical cancer
Q35234992	DNA vaccines for cervical cancer: from bench to bedside
Q43572262	DNA- versus RNA-based methods for human papillomavirus detection in cervical neoplasia
Q88924776	Deciphering the cells of origin of squamous cell carcinomas
Q45983012	Decreased expression of DNA repair genes (XRCC1, ERCC1, ERCC2, and ERCC4) in squamous intraepithelial lesion and invasive squamous cell carcinoma of the cervix.
Q38953040	Deoxyelephantopin impairs growth of cervical carcinoma SiHa cells and induces apoptosis by targeting multiple molecular signaling pathways
Q35168191	Dependence of intracellular and exosomal microRNAs on viral E6/E7 oncogene expression in HPV-positive tumor cells
Q33602929	Depletion of the cdk inhibitor p16INK4a differentially affects proliferation of established cervical carcinoma cells
Q57248064	Deregulation of RNA polymerase III transcription in cervical epithelium in response to high-risk human papillomavirus
Q54431224	Deregulation of STAT-5 isoforms in the development of HPV-mediated cervical carcinogenesis.
Q34717857	Deregulation of eIF4E: 4E-BP1 in differentiated human papillomavirus-containing cells leads to high levels of expression of the E7 oncoprotein
Q37485899	Destabilization of Rb by human papillomavirus E7 is cell cycle dependent: E2-25K is involved in the proteolysis
Q30431944	Destabilization of TIP60 by human papillomavirus E6 results in attenuation of TIP60-dependent transcriptional regulation and apoptotic pathway
Q54411999	Detection and quantification of human papillomavirus genital infections: virological, epidemiological, and clinical applications
Q34105003	Detection and quantitation of HPV in genital and oral tissues and fluids by real time PCR.
Q54518397	Detection and typing of human papillomaviruses combining different methods: polymerase chain reaction, restriction fragment length polymorphism, line probe assay and sequencing.
Q42248573	Detection of E6-AP as a potential therapeutic target in cervical specimen of HPV-infected women
Q35792128	Detection of Genomic Amplification of the Human Telomerase Gene (TERC) in Cytologic Specimens as a Genetic Test for the Diagnosis of Cervical Dysplasia
Q50033722	Detection of HPV16 in Esophageal Cancer in a High-Incidence Region of Malawi
Q58560056	Detection of High-Risk Human Papillomavirus in Oral Cavity Squamous Cell Carcinoma Using Multiple Analytes and Their Role in Patient Survival
Q44966448	Detection of High-Risk Mucosal Human Papillomavirus DNA in Human Specimens by a Novel and Sensitive Multiplex PCR Method Combined with DNA Microarray
Q35907151	Detection of Human Papillomavirus Infections at the Single-Cell Level
Q42479511	Detection of human papilloma virus in normal skin and in superficial and nodular basal cell carcinomas in immunocompetent subjects.
Q51573977	Detection of human papillomavirus DNA by DNA chip in breast carcinomas of Korean women.
Q36179744	Detection of human papillomavirus in Chinese esophageal squamous cell carcinoma and its adjacent normal epithelium
Q35689066	Detection of human papillomavirus type 18 E7 oncoprotein in cervical smears: a feasibility study
Q36648343	Detection of human papillomavirus-16 in ovarian malignancy
Q56941300	Detection of hypermethylated genes as markers for cervical screening in women living with HIV
Q41006849	Detection of hypermutated human papillomavirus type 16 genome by Next-Generation Sequencing
Q40379382	Detection of novel papillomaviruses in canine mucosal, cutaneous and in situ squamous cell carcinomas.
Q38616578	Developing a Smoking Cessation Intervention for Low Income and Minority Women
Q34786808	Developing vaccines against minor capsid antigen L2 to prevent papillomavirus infection
Q35552591	Development of HPV Vaccines for HPV-associated Head and Neck Squamous Cell Carcinoma
Q39605697	Development of a cellular assay system to study the genome replication of high- and low-risk mucosal and cutaneous human papillomaviruses
Q40910986	Development of a cervical cancer progress prediction tool for human papillomavirus-positive Koreans: A support vector machine-based approach
Q53487953	Development of a novel viral DNA vaccine against human papillomavirus: AcHERV-HP16L1.
Q41973830	Development of a sensitive and specific multiplex PCR method combined with DNA microarray primer extension to detect Betapapillomavirus types
Q35145250	Diagnostic value of MCM2 immunocytochemical staining in cervical lesions and its relationship with HPV infection
Q55230646	Dietary inflammatory index and risk of upper aerodigestive tract cancer in Japanese adults.
Q79157545	Differences in imiquimod treatment outcome in two patients with bowenoid papulosis containing either episomal or integrated human papillomavirus 16
Q40670809	Differences in the ubiquitination of p53 by Mdm2 and the HPV protein E6.
Q39952056	Differences in transcriptional activity of cutaneous human papillomaviruses
Q33235943	Different papillomaviruses have different repertoires of transcription factor binding sites: convergence and divergence in the upstream regulatory region
Q42409940	Different regions of the HPV-E7 and Ad-E1A viral oncoproteins bind competitively but through distinct mechanisms to the CH1 transactivation domain of p300.
Q34019049	Differential methylation of the HPV 16 upstream regulatory region during epithelial differentiation and neoplastic transformation
Q34243863	Differential regulation of cutaneous oncoprotein HPVE6 by wtp53, mutant p53R248W and ΔNp63α is HPV type dependent
Q56902522	Differential regulation of the Wnt/β-catenin pathway by hepatitis C virus recombinants expressing core from various genotypes
Q40327353	Digital image analysis of AgNORs in cervical smears of women with premalignant and malignant lesions of the uterine cervix.
Q40008977	Direct activation of cyclin-dependent kinase 2 by human papillomavirus E7.
Q35928124	Direct identification of an HPV-16 tumor antigen from cervical cancer biopsy specimens
Q35592783	Discovering new medicines targeting helicases: challenges and recent progress
Q34022393	Disruption of HPV16-E7 by CRISPR/Cas system induces apoptosis and growth inhibition in HPV16 positive human cervical cancer cells
Q34783855	Disruption of human papillomavirus 16 E6 gene by clustered regularly interspaced short palindromic repeat/Cas system in human cervical cancer cells
Q54565226	Distribution and viral load of eight oncogenic types of human papillomavirus (HPV) and HPV 16 integration status in cervical intraepithelial neoplasia and carcinoma.
Q36102386	Distribution of HPV Genotype in Invasive Cervical Carcinoma and Cervical Intraepithelial Neoplasia in Zhejiang Province, Southeast China: Establishing the Baseline for Surveillance
Q42227320	Diverse expression levels of two codon-optimized genes that encode human papilloma virus type 16 major protein L1 in Hansenula polymorpha
Q43008521	Does human papillomavirus cause pterygium?
Q35774362	Down-regulated nucleoside diphosphate kinase nm23-H1 expression is unrelated to high-risk human papillomavirus but associated with progression of cervical intraepithelial neoplasia and unfavourable prognosis in cervical cancer.
Q58605666	Down-regulation of HPGD by miR-146b-3p promotes cervical cancer cell proliferation, migration and anchorage-independent growth through activation of STAT3 and AKT pathways
Q38451967	Down-regulation of MALAT1 inhibits cervical cancer cell invasion and metastasis by inhibition of epithelial-mesenchymal transition
Q36470168	Down-regulation of transforming growth factor-beta type II receptor (TGF-betaRII) protein and mRNA expression in cervical cancer
Q48148048	Downregulation of 15-hydroxyprostaglandin dehydrogenase by interleukin-1β from activated macrophages leads to poor prognosis in pancreatic cancer
Q64079454	Downregulation of microRNA-425-5p suppresses cervical cancer tumorigenesis by targeting AIFM1
Q85635461	Downregulation of tumor suppressor gene PML in uterine cervical carcinogenesis: impact of human papillomavirus infection (HPV)
Q35774348	Dynamic behavioural interpretation of cervical intraepithelial neoplasia with molecular biomarkers
Q42425041	Dynamic localization of the human papillomavirus type 11 origin binding protein E2 through mitosis while in association with the spindle apparatus
Q35116264	E2 proteins of high risk human papillomaviruses down-modulate STING and IFN-κ transcription in keratinocytes
Q28270038	E3 ubiquitin ligase E6AP-mediated TSC2 turnover in the presence and absence of HPV16 E6
Q40258382	E5 protein of human papillomavirus 16 downregulates HLA class I and interacts with the heavy chain via its first hydrophobic domain
Q35140477	E6 and E7 from human papillomavirus type 16 cooperate to target the PDZ protein Na/H exchange regulatory factor 1.
Q36414343	E6 and E7 gene silencing results in decreased methylation of tumor suppressor genes and induces phenotype transformation of human cervical carcinoma cell lines
Q45391153	E6 and E7 variants of human papillomavirus-16 and -52 in Japan, the Philippines, and Vietnam
Q39948840	E6 proteins from multiple human betapapillomavirus types degrade Bak and protect keratinocytes from apoptosis after UVB irradiation
Q39917232	E6 variants of human papillomavirus 18 differentially modulate the protein kinase B/phosphatidylinositol 3-kinase (akt/PI3K) signaling pathway
Q39387632	E6-Specific Detection and Typing of Human Papillomaviruses in Oral Cavity Specimens from Iranian Patients
Q92511286	E6/E7 and E6* From HPV16 and HPV18 Upregulate IL-6 Expression Independently of p53 in Keratinocytes
Q35139643	E6/E7 expression of human papillomavirus type 20 (HPV-20) and HPV-27 influences proliferation and differentiation of the skin in UV-irradiated SKH-hr1 transgenic mice
Q42497221	E6/E7 expression of human papillomavirus types in cutaneous squamous cell dysplasia and carcinoma in immunosuppressed organ transplant recipients
Q40346484	E6AP and calmodulin reciprocally regulate estrogen receptor stability.
Q37127984	E7 oncoprotein of novel human papillomavirus type 108 lacking the E6 gene induces dysplasia in organotypic keratinocyte cultures
Q40119878	E7 properties of mucosal human papillomavirus types 26, 53 and 66 correlate with their intermediate risk for cervical cancer development
Q40091834	ERAP1 overexpression in HPV-induced malignancies: A possible novel immune evasion mechanism
Q26852611	Early Defensive Mechanisms against Human Papillomavirus Infection
Q36365011	Early Human Papilloma Virus (HPV) Oncogenic Influences in Breast Cancer
Q35427604	Early detection in head and neck cancer - current state and future perspectives
Q37188108	Early detection of cervical carcinomas: finding an overall approach
Q26786103	Early-life exposures to infectious agents and later cancer development
Q51773219	Ecological Association of Human Papillomavirus Vaccination with Cervical Dysplasia Prevalence in the United States, 2007-2014.
Q90136444	Effect of HPV Infection on the Occurrence and Development of Laryngeal Cancer: A Review
Q28254507	Effect of high-risk human papillomavirus oncoproteins on p53R2 gene expression after DNA damage
Q28273926	Effect of transforming viruses on molecular mechanisms associated with cancer
Q54190110	Effects of MDM2 promoter polymorphisms on the development of cervical neoplasia in a Southeastern Brazilian population.
Q35999045	Efficacy and other milestones for human papillomavirus vaccine introduction
Q31160231	Efficacy and safety of hexaminolevulinate photodynamic therapy in patients with low-grade cervical intraepithelial neoplasia
Q52562511	Efficacy of antiviral drug AV2 in the treatment of human papillomavirus-associated precancerous lesions of the uterine cervix: A randomized placebo-controlled clinical trial in Kinshasa, DR Congo. (KINVAV study).
Q64982398	Efficacy of commercially available biological agents for the topical treatment of cervical intraepithelial neoplasia: a systematic review.
Q92459692	Efficient Inhibition of Human Papillomavirus Infection by L2 Minor Capsid-Derived Lipopeptide
Q34988558	Eight nucleotide substitutions inhibit splicing to HPV-16 3'-splice site SA3358 and reduce the efficiency by which HPV-16 increases the life span of primary human keratinocytes
Q37071119	Elevated glucose-6-phosphate dehydrogenase expression in the cervical cancer cases is associated with the cancerigenic event of high-risk human papillomaviruses
Q45969444	Elimination of high-risk human papillomavirus type HPV16 infection by 'Praneem' polyherbal tablet in women with early cervical intraepithelial lesions.
Q35838585	Emergent human pathogen simian virus 40 and its role in cancer.
Q35098322	Emerging drugs to treat squamous cell carcinomas of the head and neck
Q36066004	Emerging human papillomavirus vaccines
Q56967486	Emerging human papillomavirus vaccines
Q26744051	Emerging role of sphingosine-1-phosphate signaling in head and neck squamous cell carcinoma
Q37858935	Emerging topics in human tumor virology
Q36671829	Endocervical glandular neoplasia associated with lobular endocervical glandular hyperplasia is HPV-independent and correlates with carbonic anhydrase-IX expression: a Gynaecological Oncology Group Study
Q33755082	Endoplasmic reticulum-localized human papillomavirus type 16 E5 protein alters endosomal pH but not trans-Golgi pH.
Q36559588	Engagement of the ATR-dependent DNA damage response at the human papillomavirus 18 replication centers during the initial amplification
Q55086081	Engineered T cells targeting E7 mediate regression of human papillomavirus cancers in a murine model.
Q53428359	Enhancement of immunotherapeutic effects of HPV16E7 on cervical cancer by fusion with CTLA4 extracellular region.
Q90219737	Epidemiology of Head and Neck Squamous Cell Carcinomas: Impact on Staging and Prevention Strategies
Q42690821	Epidemiology of cervical human papillomavirus (HPV) infection and squamous intraepithelial lesions (SIL) among a cohort of HIV-infected and uninfected Ghanaian women
Q37669732	Epidemiology of oral human papillomavirus infection
Q90437506	Epidermal growth factor receptor and Abl2 kinase regulate distinct steps of Human papillomavirus type 16 endocytosis
Q39468273	Epidermal growth factor-stimulated human cervical cancer cell growth is associated with EGFR and cyclin D1 activation, independent of COX-2 expression levels
Q35234948	Epigallocatechin-3-gallate enhances CD8+ T cell-mediated antitumor immunity induced by DNA vaccination.
Q92702483	Epigenetic Dysregulation at the Crossroad of Women's Cancer
Q38667127	Epigenetic Dysregulation in Virus-Associated Neoplasms
Q37906492	Epigenetic consequences of foreign DNA insertions: de novo methylation and global alterations of methylation patterns in recipient genomes
Q38821651	Epigenetic inactivation of TRAIL decoy receptors at 8p12-21.3 commonly deleted region confers sensitivity to Apo2L/trail-Cisplatin combination therapy in cervical cancer.
Q37007058	Epigenetic mechanisms in penile carcinoma
Q35178132	Epigenetic regulation of inflammatory cytokines and associated genes in human malignancies
Q37615798	Epigenetics of oropharyngeal squamous cell carcinoma: opportunities for novel chemotherapeutic targets
Q38562421	Epithelial barrier and oral bacterial infection
Q57185645	Epithelial boost enhances antigen expression by vaccinia virus for the generation of potent CD8+ T cell-mediated antitumor immunity following DNA priming vaccination
Q35747467	Epithelial-mesenchymal transition in cervical carcinoma.
Q33743226	Epitope design of L1 protein for vaccine production against Human Papilloma Virus types 16 and 18
Q48028662	Eradication of established HPV 16-expressing tumors by a single administration of a vaccine composed of a liposome-encapsulated CTL-T helper fusion peptide in a water-in-oil emulsion
Q38311773	ErbB4 (JM-b/CYT-1)-induced expression and phosphorylation of c-Jun is abrogated by human papillomavirus type 16 E5 protein
Q43829694	Esophageal squamous cell cancer in patients with head and neck cancer: Prevalence of human papillomavirus DNA sequences
Q34162277	Essential roles for soluble virion-associated heparan sulfonated proteoglycans and growth factors in human papillomavirus infections.
Q28474811	Establishment of human papillomavirus infection requires cell cycle progression
Q36022496	Establishment of immunoassay for detecting HPV16 E6 and E7 RNA.
Q34037344	Estrogen and ERalpha: culprits in cervical cancer?
Q33850511	Estrogen contributes to the onset, persistence, and malignant progression of cervical cancer in a human papillomavirus-transgenic mouse model
Q30239987	Eurogin 2016 Roadmap: how HPV knowledge is changing screening practice
Q41674446	Evaluation of Cell Penetrating Peptide Delivery System on HPV16E7 Expression in Three Types of Cell Line
Q51572189	Evaluation of Fanconi anaemia genes FANCA, FANCC and FANCL in cervical cancer susceptibility.
Q36423738	Evaluation of a commercialized in situ hybridization assay for detecting human papillomavirus DNA in tissue specimens from patients with cervical intraepithelial neoplasia and cervical carcinoma
Q50134597	Evaluation of immune responses induced by a novel human papillomavirus type 16 E7 peptide-based vaccine with Candida skin test reagent as an adjuvant in C57BL/6 mice
Q53327162	Evaluation of matrix metalloproteinase 2 expression in cervical carcinogenesis using tissue array and integrated optical density for immunoreactivity.
Q92275390	Evaluation of p16/Ki-67 Dual Staining Compared with HPV Genotyping in Anal Cytology with Diagnosis of ASC-US for Detection of High-Grade Anal Intraepithelial Lesions
Q44187732	Evidence for an association of human papillomavirus and breast carcinomas
Q48015365	Evidence for an endogenous papillomavirus-like element in the platypus genome
Q35949495	Evidence for practice: oral contraception and risk of cervical cancer
Q35742087	Evidence of recombination within human alpha-papillomavirus
Q84534943	Exhortations to abandon the Pap test as a routine initial cervical screening test are still premature and carry significant risks
Q40092337	Exosomes and Other Extracellular Vesicles in HPV Transmission and Carcinogenesis
Q37807402	Exploiting the therapeutic potential of microRNAs in viral diseases: expectations and limitations
Q54962616	Exploration of the molecular mechanisms of cervical cancer based on mRNA expression profiles and predicted microRNA interactions.
Q37248898	Exposure profiles and human papillomavirus infection in skin cancer: an analysis of 25 genus beta-types in a population-based study
Q45110374	Exposure to wood smoke, HPV infection, and genetic susceptibility for cervical neoplasia among women in Colombia
Q35683961	Expression Quantitative Trait Loci for CARD8 Contributes to Risk of Two Infection-Related Cancers--Hepatocellular Carcinoma and Cervical Cancer
Q39690666	Expression and methylation status of the Syk gene in cervical carcinoma
Q37516391	Expression of E6, p53 and p21 proteins and physical state of HPV16 in cervical cytologies with and without low grade lesions
Q59357206	Expression of HPV-induced DNA Damage Repair Factors Correlates With CIN Progression
Q64914998	Expression of PD-L1 in cervical carcinoma and its impact on survival associated with T-cell infiltration and FoxP3 expression.
Q37345331	Expression of activated signal transducer and activator of transcription-3 predicts poor prognosis in cervical squamous-cell carcinoma.
Q37254338	Expression of betapapillomavirus oncogenes increases the number of keratinocytes with stem cell-like properties
Q37125290	Expression of human papilloma virus type 16 E5 protein in amelanotic melanoma cells regulates endo-cellular pH and restores tyrosinase activity
Q34572180	Expression of human papillomavirus type 16 E7 is sufficient to significantly increase expression of angiogenic factors but is not sufficient to induce endothelial cell migration
Q39357637	Expression of mitochondrial non-coding RNAs (ncRNAs) is modulated by high risk human papillomavirus (HPV) oncogenes.
Q53604457	Expression of p16 and hTERT protein is associated with the presence of high-risk human papillomavirus in Bowenoid papulosis.
Q54586717	Expression of p16(INK4A), p53, and Rb proteins are independent from the presence of human papillomavirus genes in oral squamous cell carcinoma.
Q34733313	Expression of transcription factor grainyhead-like 2 is diminished in cervical cancer
Q40097092	Expression optimization of a cell membrane-penetrating human papillomavirus type 16 therapeutic vaccine candidate in Nicotiana benthamiana
Q47308372	Expression profile of microRNA-146a along HPV-induced multistep carcinogenesis: a study in HPV16 transgenic mice.
Q35993181	Expression quantitative trait loci in long non-coding RNA ZNRD1-AS1 influence cervical cancer development
Q36662802	Expression, purification and characterization of a recombinant fusion protein based on the human papillomavirus-16 E7 antigen
Q41177224	Expressions of E2 and E7-HPV16 proteins in pre-malignant and malignant lesions of the uterine cervix
Q37564524	Extremely stringent activation of p16INK4a prevents immortalization of uterine cervical epithelial cells without human papillomavirus oncogene expression.
Q34687396	Eyebrow hairs from actinic keratosis patients harbor the highest number of cutaneous human papillomaviruses
Q59360209	Ezrin-Radixin-Moesin Binding Phosphoprotein 50: A Potential Novel Biomarker in Human Papilloma Virus-Associated Head and Neck Squamous Cell Carcinomas
Q35789859	Facile, comprehensive, high-throughput genotyping of human genital papillomaviruses using spectrally addressable liquid bead microarrays
Q59355532	Familial Ovarian Cancer Clusters with Other Cancers
Q40072676	Familial associations of male breast cancer with other cancers
Q48263482	Feasibility study of a human papillomavirus E6 and E7 oncoprotein test for the diagnosis of cervical precancer and cancer.
Q33733199	Feedback between E2F1 and CIP2A regulated by human papillomavirus E7 in cervical cancer: implications for prognosis
Q64067322	FightHPV: Design and Evaluation of a Mobile Game to Raise Awareness About Human Papillomavirus and Nudge People to Take Action Against Cervical Cancer
Q37667998	Fighting Viral Infections and Virus-Driven Tumors with Cytotoxic CD4+ T Cells
Q44173679	First-generation vaccines against human papillomavirus
Q64068174	Folate Repletion after Deficiency Induces Irreversible Genomic and Transcriptional Changes in Human Papillomavirus Type 16 (HPV16)-Immortalized Human Keratinocytes
Q36459298	Folate and vitamin B12 may play a critical role in lowering the HPV 16 methylation-associated risk of developing higher grades of CIN.
Q95728219	Follow-Up of Women with Cervical Cytological Abnormalities: Progression and Regression Events
Q92587901	From prevention to cure, repurposing anti-viral vaccines for cancer immunotherapy
Q28078631	Functional Roles of E6 and E7 Oncoproteins in HPV-Induced Malignancies at Diverse Anatomical Sites
Q38671633	Functional assessment and structural basis of antibody binding to human papillomavirus capsid
Q39073259	Functional effects of sequence variations in the E6 and E2 genes of human papillomavirus 16 European and Asian variants
Q37024935	Functional regulatory role of STAT3 in HPV16-mediated cervical carcinogenesis
Q36180589	Functional variants of human papillomavirus type 16 demonstrate host genome integration and transcriptional alterations corresponding to their unique cancer epidemiology.
Q34275134	Fusion of CTLA-4 with HPV16 E7 and E6 enhanced the potency of therapeutic HPV DNA vaccine
Q38730588	GRWD1 negatively regulates p53 via the RPL11-MDM2 pathway and promotes tumorigenesis.
Q41683289	Gallic acid induces apoptosis in human cervical epithelial cells containing human papillomavirus type 16 episomes
Q35153915	Gankyrin is frequently overexpressed in cervical high grade disease and is associated with cervical carcinogenesis and metastasis
Q33206406	Gender Differences in Bacterial STIs in Canada
Q35654387	Gene Silencing and Activation of Human Papillomavirus 18 Is Modulated by Sense Promoter Associated RNA in Bidirectionally Transcribed Long Control Region
Q33803034	Gene amplification of EGFR and its clinical significance in various cervical (lesions) lesions using cytology and FISH
Q36982644	Gene discovery in cervical cancer : towards diagnostic and therapeutic biomarkers
Q53676632	Gene expression profiling of dysplastic differentiation in cervical epithelial cells harboring human papillomavirus 16.
Q28119171	Gene network reconstruction reveals cell cycle and antiviral genes as major drivers of cervical cancer
Q36922247	Gene therapy of gynaecological diseases
Q36482161	Generation and characterization of a preventive and therapeutic HPV DNA vaccine
Q47230963	Genetic patterns in head and neck cancers that contain or lack transcriptionally active human papillomavirus
Q35159691	Genetic stability of a recombinant adenovirus vaccine vector seed library expressing human papillomavirus type 16 E6 and E7 proteins
Q36683202	Genetic susceptibility of cervical cancer
Q59357470	Genetic variability and lineage phylogeny of human papillomavirus type 45 based on E6 and E7 genes in Southwest China
Q30399597	Genetic variability in E6, E7 and L1 genes of Human Papillomavirus 62 and its prevalence in Mexico.
Q45359916	Genetic variant of CCND1: association with HPV-mediated cervical cancer in Indian population
Q45672474	Genetic variants in HLA-DP/DQ contribute to risk of cervical cancer: a two-stage study in Chinese women
Q35043973	Genetic variation of human papillomavirus type 16 in individual clinical specimens revealed by deep sequencing.
Q37518900	Genome sequencing accuracy by RCA-seq versus long PCR template cloning and sequencing in identification of human papillomavirus type 58.
Q36332540	Genome variation of human papillomavirus types: phylogenetic and medical implications
Q42674338	Genome-wide DNA copy number alterations in head and neck squamous cell carcinomas with or without oncogene-expressing human papillomavirus
Q36377758	Genome-wide discovery of viral microRNAs based on phylogenetic analysis and structural evolution of various human papillomavirus subtypes
Q38920757	Genome-wide profiling of HPV integration in cervical cancer identifies clustered genomic hot spots and a potential microhomology-mediated integration mechanism
Q37349142	Genome-wide profiling of the human papillomavirus DNA integration in cervical intraepithelial neoplasia and normal cervical epithelium by HPV capture technology
Q30490930	Genomewide gene expression profiles of HPV-positive and HPV-negative oropharyngeal cancer: potential implications for treatment choices
Q35020487	Genomic Instability Induced By Human Papillomavirus Oncogenes
Q24675639	Genomic amplification of the human telomerase gene (TERC) in pap smears predicts the development of cervical cancer
Q38188515	Genomic and transcriptional alterations of cholangiocarcinoma
Q90726984	Genomic characterization of cervical cancer based on human papillomavirus status
Q39304407	Genomic diversity and phylogenetic relationships of human papillomavirus 16 (HPV16) in Nepal
Q35752761	Genomic instability of the host cell induced by the human papillomavirus replication machinery
Q33457679	Genomic profiling identifies common HPV-associated chromosomal alterations in squamous cell carcinomas of cervix and head and neck.
Q38776454	Genomic sequencing and precision medicine in head and neck cancers
Q33491832	Genotype distribution of human papillomavirus (HPV) and co-infections in cervical cytologic specimens from two outpatient gynecological clinics in a region of southeast Spain
Q36540527	Genotype distribution of human papillomaviruses in Japanese women with abnormal cervical cytology.
Q38846847	Genotypic diversity of anogenital human papillomavirus in women attending cervical cancer screening in Harare, Zimbabwe
Q42221192	Genotyping of high-risk human papillomaviruses in p16/Ki-67-positive urothelial carcinoma cells: even a worm will turn
Q33346247	Germline mutation in RNASEL predicts increased risk of head and neck, uterine cervix and breast cancer
Q36742100	Girdin expression in cervical carcinoma and its role in the malignant properties of HeLa cells
Q56889497	Glycogene expression profiles based on microarray data from cervical carcinoma HeLa cells with partially silenced E6 and E7 HPV oncogenes
Q40104911	Going viral? Linking the etiology of human prostate cancer to the PCA3 long noncoding RNA and oncogenic viruses.
Q37484683	Grading the severity of cervical neoplasia based on combined histopathology, cytopathology, and HPV genotype distribution among 1,700 women referred to colposcopy in Oklahoma
Q42707227	Growth inhibition of HeLa cells is a conserved feature of high-risk human papillomavirus E8^E2C proteins and can also be achieved by an artificial repressor protein.
Q33883959	Growth suppression induced by downregulation of E6-AP expression in human papillomavirus-positive cancer cell lines depends on p53
Q37066141	Guidelines of the Italian Society for Virology on HPV testing and vaccination for cervical cancer prevention
Q38342582	HDAC inhibitors trigger apoptosis in HPV-positive cells by inducing the E2F-p73 pathway.
Q30444132	HECT E3s and human disease
Q33760203	HIPK2 Overexpression and Its Prognostic Role in Human Papillomavirus-Positive Tonsillar Squamous Cell Carcinoma.
Q40340610	HLA-DP is the cervical cancer susceptibility loci among women infected by high-risk human papillomavirus: potential implication for triage of human papillomavirus-positive women.
Q35234918	HLA-DQB1*02-restricted HPV-16 E7 peptide-specific CD4+ T-cell immune responses correlate with regression of HPV-16-associated high-grade squamous intraepithelial lesions
Q36346449	HLA-E expression in cervical adenocarcinomas: association with improved long-term survival.
Q96135855	HOXA5 inhibits the proliferation and neoplasia of cervical cancer cells via downregulating the activity of the Wnt/β-catenin pathway and transactivating TP53
Q40827858	HPV 16 E7 inhibits OSCC cell proliferation, invasion, and metastasis by upregulating the expression of miR-20a
Q36428297	HPV 16E7 and 48E7 proteins use different mechanisms to target p130 to overcome cell cycle block
Q37566987	HPV DNA in saliva from patients with SCC of the head and neck is specific for p16-positive oropharyngeal tumours
Q33885602	HPV DNA is associated with a subset of Schneiderian papillomas but does not correlate with p16(INK4a) immunoreactivity
Q36679727	HPV DNA testing for cervical cancer screening. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer
Q91704461	HPV E6 and E7 oncoproteins cooperatively alter the expression of Disc Large 1 polarity protein in epithelial cells
Q33384291	HPV E6, E6AP and cervical cancer
Q34048160	HPV E6/E7 mRNA testing is more specific than cytology in post-colposcopy follow-up of women with negative cervical biopsy
Q36878717	HPV E6/p53 mediated down-regulation of miR-34a inhibits Warburg effect through targeting LDHA in cervical cancer
Q39998431	HPV E7 contributes to the telomerase activity of immortalized and tumorigenic cells and augments E6-induced hTERT promoter function
Q36238070	HPV Genotyping of Modified General Primer-Amplicons Is More Analytically Sensitive and Specific by Sequencing than by Hybridization.
Q38971534	HPV Integration in Head and Neck Squamous Cell Carcinomas: Cause and Consequence
Q89834860	HPV Oncoproteins and the Ubiquitin Proteasome System: A Signature of Malignancy?
Q41648773	HPV Status Determines the Efficacy of Adjuvant Chemotherapy With S-1, an Oral Fluorouracil Prodrug, in Oropharyngeal Cancer
Q28081656	HPV and cancer of the oral cavity
Q37144878	HPV and oral lesions: preventive possibilities, vaccines and early diagnosis of malignant lesions
Q33931195	HPV episome levels are potently decreased by pyrrole-imidazole polyamides.
Q36888568	HPV genotype distribution according to severity of cervical neoplasia using the Digene HPV genotyping LQ test.
Q62660928	HPV genotype prevalence in cytologically abnormal cervical samples from women living in south Italy
Q36774457	HPV genotypes in paraffin sections of non-cervical squamous cell carcinoma in Qingdao of China
Q34995797	HPV genotypes in the oral cavity/oropharynx of children and adolescents: cross-sectional survey in Poland.
Q24631711	HPV in exhaled breath condensate of lung cancer patients
Q53345674	HPV in oral squamous cell carcinomas of a Brazilian population: amplification by PCR.
Q37213653	HPV infection and p53 inactivation in pterygium
Q51849016	HPV infection in esophageal squamous cell carcinoma and its relationship to the prognosis of patients in northern China.
Q64938539	HPV infection in semen: results from a new molecular approach.
Q37145093	HPV infection: immunological aspects and their utility in future therapy
Q64106053	HPV insertional pattern as a personalized tumor marker for the optimized tumor diagnosis and follow-up of patients with HPV-associated carcinomas: a case report
Q43653961	HPV involvement in tonsillar cancer: prognostic significance and clinically relevant markers
Q34535660	HPV mRNA is more specific than HPV DNA in triage of women with minor cervical lesions
Q33762996	HPV mRNA tests for the detection of cervical intraepithelial neoplasia: a systematic review
Q50514468	HPV molecular assays: defining analytical and clinical performance characteristics for cervical cytology specimens
Q42203937	HPV prevalence and type distribution in women with normal or abnormal Pap smear in Bulgaria
Q80977506	HPV testing in the follow-up after treatment of women with CIN
Q92570253	HPV type 16 E6 and NFX1-123 augment JNK signaling to mediate keratinocyte differentiation and L1 expression
Q47321818	HPV types in cervical cancer tissue in South Africa: A head-to-head comparison by mRNA and DNA tests
Q54348122	HPV typing and its relation with apoptosis in cervical carcinoma from Indian population.
Q42376432	HPV vaccination in boys: Determining the clinical relevance of this strategy
Q40265515	HPV vaccines: Global perspectives
Q37948622	HPV, KRAS mutations, alcohol consumption and tobacco smoking effects on esophageal squamous-cell carcinoma carcinogenesis.
Q42241871	HPV-16 E2 contributes to induction of HPV-16 late gene expression by inhibiting early polyadenylation
Q42270718	HPV-16 E6 and E7 protein T cell epitopes prediction analysis based on distributions of HLA-A loci across populations: an in silico approach
Q35441106	HPV-16 impairs the subcellular distribution and levels of expression of protein phosphatase 1γ in cervical malignancy
Q47552780	HPV-16 virions can remain infectious for 2 weeks on senescent cells but require cell cycle re-activation to allow virus entry
Q57468706	HPV-18 E6 Oncoprotein and Its Spliced Isoform E6*I Regulate the Wnt/β-Catenin Cell Signaling Pathway through the TCF-4 Transcriptional Factor
Q24310037	HPV-18 E7 conjugates to c-Myc and mediates its transcriptional activity
Q44789095	HPV-associated tonsillar cancer. An update
Q90805909	HPV-based cervical screening: Rationale, expectations and future perspectives of the new Dutch screening programme
Q34998465	HPV-positive oropharyngeal squamous cell carcinoma is associated with TIMP3 and CADM1 promoter hypermethylation
Q38851565	HPV-type-specific response of cervical cancer cells to cisplatin after silencing replication licensing factor MCM4.
Q64975491	HPV-vaccination and cancer cervical screening in 53 WHO European Countries: An update on prevention programs according to income level.
Q35832368	HPV16 E5 deregulates the autophagic process in human keratinocytes
Q38934698	HPV16 E5 expression induces switching from FGFR2b to FGFR2c and epithelial-mesenchymal transition
Q38693402	HPV16 E6 and E7 Upregulate Interferon-Induced Antiviral Response Genes ISG15 and IFIT1 in Human Trophoblast Cells
Q58377934	HPV16 E6 augments Wnt signaling in an E6AP-dependent manner
Q37107651	HPV16 E6 upregulates Aurora A expression
Q42232821	HPV16 E6 variants: frequency, association with HPV types and in silico analysis of the identified novel variants
Q37636751	HPV16 E6-E7 induces cancer stem-like cells phenotypes in esophageal squamous cell carcinoma through the activation of PI3K/Akt signaling pathway in vitro and in vivo
Q40200580	HPV16 E6-mediated stabilization of ErbB2 in neoplastic transformation of human cervical keratinocytes
Q39833779	HPV16 E7 oncogene expression in normal human epithelial cells causes molecular changes indicative of an epithelial to mesenchymal transition
Q36557809	HPV16 genetic variation and the development of cervical cancer worldwide
Q42254022	HPV16 genotype, p16/Ki-67 dual staining and koilocytic morphology as potential predictors of the clinical outcome for cervical low-grade squamous intraepithelial lesions.
Q43694713	HPV16, HPV18, and HIV infection may influence cervical cytokine intralesional levels
Q42066953	HPV18 E1^E4 is assembled into aggresome-like compartment and involved in sequestration of viral oncoproteins
Q64247518	HPV18 Utilizes Two Alternative Branch Sites for E6*I Splicing to Produce E7 Protein
Q39030160	HPV8 early genes modulate differentiation and cell cycle of primary human adult keratinocytes.
Q35884544	HPVbase--a knowledgebase of viral integrations, methylation patterns and microRNAs aberrant expression: As potential biomarkers for Human papillomaviruses mediated carcinomas
Q30794549	HPVdb: a data mining system for knowledge discovery in human papillomavirus with applications in T cell immunology and vaccinology
Q98881852	HPVomics: An integrated resource for the human papillomavirus epitome and therapeutics
Q33805498	HUMAN PAPILLOMAVIRUS ASSOCIATION WITH HEAD AND NECK CANCERS: UNDERSTANDING VIRUS BIOLOGY AND USING IT IN THE DEVELOPMENT OF CANCER DIAGNOSTICS
Q36730743	Harnessing the Prokaryotic Adaptive Immune System as a Eukaryotic Antiviral Defense
Q45024333	Health biotechnology innovation on a global stage
Q35860988	Heterogeneous Nuclear Ribonucleoprotein C Proteins Interact with the Human Papillomavirus Type 16 (HPV16) Early 3'-Untranslated Region and Alleviate Suppression of HPV16 Late L1 mRNA Splicing
Q36219980	High Expression of KIF20A Is Associated with Poor Overall Survival and Tumor Progression in Early-Stage Cervical Squamous Cell Carcinoma
Q36557930	High Prevalence of Human Papillomavirus in Colorectal Cancer in Hispanics: A Case-Control Study.
Q38645976	High Risk Alpha Papillomavirus Oncogenes Impair the Homologous Recombination Pathway
Q59351122	High frequency of HPV16 European variant E350G among Mexican women from Sinaloa
Q43514433	High levels of granzyme B expression in invasive cervical carcinoma correlates to poor response to treatment
Q34065359	High prevalence of HPV in non-cervical sites of women with abnormal cervical cytology
Q40101782	High prevalence of co-infection between human papillomavirus (HPV) 51 and 52 in Mexican population
Q34231736	High prevalence of human papillomavirus infections in urine samples from human immunodeficiency virus-infected men.
Q34460976	High risk HPV contamination of endocavity vaginal ultrasound probes: an underestimated route of nosocomial infection?
Q54377755	High risk human papillomavirus genotyping in clinical samples: evaluation of different commercial tests.
Q44359880	High-risk HPV DNA detected in less than 2% of over 25,000 cytology negative imaged liquid-based Pap test samples from women 30 and older
Q33240159	High-risk human papilloma virus (HPV) and survival in patients with esophageal carcinoma: a pilot study
Q34045061	High-risk human papillomavirus (HPV) screening and detection in healthy patient saliva samples: a pilot study
Q42270066	High-risk human papillomavirus is transcriptionally active in a subset of sinonasal squamous cell carcinomas
Q54368974	High-risk human papillomavirus seems not involved in DES-related and of limited importance in nonDES related clear-cell carcinoma of the cervix.
Q28084802	High-risk human papillomavirus targets crossroads in immune signaling
Q42503469	High-risk human papillomavirus-induced expression of endothelial and inducible nitric oxide synthase in human uterine cervix
Q42218361	High-throughput and automatic typing via human papillomavirus identification map for cervical cancer screening and prognosis
Q34037232	High-throughput profiling of the humoral immune responses against thirteen human papillomavirus types by proteome microarrays.
Q35016793	High-throughput pseudovirion-based neutralization assay for analysis of natural and vaccine-induced antibodies against human papillomaviruses
Q40196754	Higher expression and activity of metalloproteinases in human cervical carcinoma cell lines is associated with HPV presence.
Q37187658	Higher prevalence and gene amplification of HPV16 in oropharynx as compared to oral cavity
Q48480777	Homage to Theodor Boveri (1862-1915): Boveri's theory of cancer as a disease of the chromosomes, and the landscape of genomic imbalances in human carcinomas
Q43269145	Homocysteine levels are associated with cervical cancer independent of methylene tetrahydrofolate reductase gene (MTHFR) polymorphisms in Indian population
Q35235035	How will HPV vaccines affect cervical cancer?
Q52662935	Human Dignity as Leading Principle in Public Health Ethics: A Multi-Case Analysis of 21st Century German Health Policy Decisions.
Q42271834	Human JC polyomavirus in normal colorectal mucosa, hyperplastic polyps, sporadic adenomas, and adenocarcinomas in Portugal.
Q38600163	Human Leukocyte Antigen Class I and Class II Polymorphisms and Serum Cytokine Profiles in Cervical Cancer.
Q39388456	Human OCTN2 (SLC22A5) is down-regulated in virus- and nonvirus-mediated cancer.
Q26798802	Human Papilloma Virus (HPV) Induced Head & Neck Squamous Cell Carcinoma: A Comprehensive Retrospect
Q33626377	Human Papilloma Virus (HPV) in head and neck region: review of literature
Q38869435	Human Papilloma Virus as a Biomarker for Personalized Head and Neck Cancer Radiotherapy
Q28078170	Human Papilloma Viruses and Breast Cancer - Assessment of Causality
Q27308147	Human Papilloma Viruses and Breast Cancer.
Q37637430	Human Papillomavirus (HPV) virion induced cancer and subfertility, two sides of the same coin
Q26822621	Human Papillomavirus (HPV)-associated Oral Cancers and Treatment Strategies
Q38721814	Human Papillomavirus 16 E6 Upregulates APOBEC3B via the TEAD Transcription Factor
Q40422515	Human Papillomavirus Downregulates the Expression of IFITM1 and RIPK3 to Escape from IFNγ- and TNFα-Mediated Antiproliferative Effects and Necroptosis
Q42832661	Human Papillomavirus and Oropharyngeal Squamous Cell Carcinoma: A Case-Control Study regarding Tobacco and Alcohol Consumption
Q40078339	Human Papillomavirus and the DNA Damage Response: Exploiting Host Repair Pathways for Viral Replication
Q34510438	Human Papillomavirus in Brazilian women with and without cervical lesions
Q38105040	Human Papillomavirus-mediated cervical cancer awareness and Gardasil vaccination: a pilot survey among North Indian women
Q35735954	Human Papillomaviruses, p16INK4a and Akt expression in basal cell carcinoma
Q33826064	Human keratinocyte cultures in the investigation of early steps of human papillomavirus infection.
Q37169150	Human papilloma virus (HPV) and host cellular interactions
Q37339777	Human papilloma virus (HPV) infection in children and adolescents.
Q37923517	Human papilloma virus (HPV) molecular diagnostics.
Q37422821	Human papilloma virus (HPV) vaccination in childhood: challenges and perspectives
Q33752967	Human papilloma virus E7 oncoprotein abrogates the p53-p21-DREAM pathway
Q61448596	Human papilloma virus and breast cancer: the role of inflammation and viral expressed proteins
Q43600041	Human papilloma virus associated head and neck cancer: A PCR based study
Q28357079	Human papilloma virus in oral cancer
Q24642690	Human papilloma virus is associated with breast cancer
Q36787632	Human papilloma virus-dependent HMGA1 expression is a relevant step in cervical carcinogenesis
Q47555534	Human papilloma virus: An etiological and prognostic factor for oral cancer?
Q47546900	Human papilloma virus: Apprehending the link with carcinogenesis and unveiling new research avenues (Review).
Q90284016	Human papillomavirus (HPV) 16 infection is not detected in rectal carcinoma
Q54623697	Human papillomavirus (HPV) typing in relation to ras oncogene mRNA expression in HPV-associated human squamous cervical neoplasia.
Q34743768	Human papillomavirus (HPV) upregulates the cellular deubiquitinase UCHL1 to suppress the keratinocyte's innate immune response
Q43722520	Human papillomavirus (HPV) vaccination: perception and practice among French general practitioners in the year since licensing.
Q39030848	Human papillomavirus (HPV)-18 E6 oncoprotein interferes with the epithelial cell polarity Par3 protein
Q33958050	Human papillomavirus 16 E5 modulates the expression of host microRNAs
Q33755672	Human papillomavirus 16 E6 contributes HIF-1α induced Warburg effect by attenuating the VHL-HIF-1α interaction
Q34153391	Human papillomavirus 16 E6 variants differ in their dysregulation of human keratinocyte differentiation and apoptosis
Q58527824	Human papillomavirus 16 E6, L1, L2 and E2 gene variants in cervical lesion progression
Q39327918	Human papillomavirus 16 L1-E7 chimeric virus like particles show prophylactic and therapeutic efficacy in murine model of cervical cancer
Q33830609	Human papillomavirus 16 non-European variants are preferentially associated with high-grade cervical lesions
Q56795649	Human papillomavirus 8 E6 disrupts terminal skin differentiation and prevents pro-Caspase-14 cleavage
Q34406542	Human papillomavirus DNA and P16(INK4A) expression in concurrent esophageal and gastric cardia cancers
Q47100199	Human papillomavirus DNA detection in plasma and cervical samples of women with a recent history of low grade or precancerous cervical dysplasia
Q42217974	Human papillomavirus DNA load and p16INK4a expression predict for local control in patients with anal squamous cell carcinoma treated with chemoradiotherapy
Q36876059	Human papillomavirus DNA methylation as a potential biomarker for cervical cancer
Q34980270	Human papillomavirus E6 and E7 oncoproteins as risk factors for tumorigenesis
Q34782173	Human papillomavirus E6 triggers upregulation of the antiviral and cancer genomic DNA deaminase APOBEC3B
Q36559551	Human papillomavirus E7 induces rereplication in response to DNA damage
Q34717182	Human papillomavirus E7 oncoprotein dysregulates steroid receptor coactivator 1 localization and function.
Q40915530	Human papillomavirus and its clinical relevance in oesophageal squamous cell carcinoma in a Kurdish population in the west of Iran.
Q37315925	Human papillomavirus and molecular considerations for cancer risk
Q37776459	Human papillomavirus and oropharynx cancer: Biology, detection and clinical implications
Q33851664	Human papillomavirus deregulates the response of a cellular network comprising of chemotactic and proinflammatory genes
Q34401417	Human papillomavirus detection in head and neck squamous cell carcinoma
Q42700772	Human papillomavirus dysregulates the cellular apparatus controlling the methylation status of H3K27 in different human cancers to consistently alter gene expression regardless of tissue of origin
Q38069444	Human papillomavirus early proteins and apoptosis
Q39789139	Human papillomavirus episome stability is reduced by aphidicolin and controlled by DNA damage response pathways
Q54713073	Human papillomavirus genomes in squamous cell carcinomas of the uterine cervix.
Q91909139	Human papillomavirus genotype-specific risk in cervical carcinogenesis
Q44252736	Human papillomavirus genotypes distribution in cervical samples from Uruguayan women
Q33638491	Human papillomavirus genotypes in cervical cancer and vaccination challenges in Zimbabwe
Q37039593	Human papillomavirus in cervical and head-and-neck cancer
Q35638798	Human papillomavirus in upper digestive tract tumors from three countries
Q37371597	Human papillomavirus infection among sexual partners attending a Sexually Transmitted Disease Clinic in Rio de Janeiro, Brazil
Q45392523	Human papillomavirus infection among young adolescents in India: impact of vaccination
Q54474617	Human papillomavirus infection and its association with cervical dysplasia in Ecuadorian women attending a private cancer screening clinic.
Q33599023	Human papillomavirus infection and its possible correlation with p63 expression in cervical cancer in Japan, Mongolia, and Myanmar
Q37013482	Human papillomavirus infection and the multistage carcinogenesis of cervical cancer
Q37271947	Human papillomavirus infection and the primary and secondary prevention of cervical cancer.
Q41747762	Human papillomavirus infection in Bowen disease: negative p53 expression, not p16(INK4a) overexpression, is correlated with human papillomavirus-associated Bowen disease
Q34464591	Human papillomavirus infection in HIV-1 infected women in Catalonia (Spain): implications for prevention of cervical cancer.
Q44016481	Human papillomavirus infection in lung and esophageal cancers: analysis of 485 Asian cases
Q40702221	Human papillomavirus infection on initiating synchronous esophageal neoplasia in patients with head and neck cancer
Q37878367	Human papillomavirus infection: etiopathogenesis, molecular biology and clinical manifestations
Q40839634	Human papillomavirus integration pattern and demographic, clinical, and survival characteristics of patients with oropharyngeal squamous cell carcinoma
Q41260492	Human papillomavirus mRNA testing for the detection of anal high-grade squamous intraepithelial lesions in men who have sex with men infected with HIV.
Q36694878	Human papillomavirus oncogenic expression in the dysplastic portio; an investigation of biopsies from 190 cervical cones
Q40890409	Human papillomavirus oncoprotein E7 targets the promyelocytic leukemia protein and circumvents cellular senescence via the Rb and p53 tumor suppressor pathways
Q47599510	Human papillomavirus oncoproteins induce a reorganization of epithelial-associated γδ T cells promoting tumor formation
Q37769103	Human papillomavirus oncoproteins: pathways to transformation
Q40841456	Human papillomavirus prevalence and genotypes distribution among female outpatients in Qingdao, East China
Q34616083	Human papillomavirus testing in the prevention of cervical cancer
Q37194934	Human papillomavirus type 16 E2 and E6 are RNA-binding proteins and inhibit in vitro splicing of pre-mRNAs with suboptimal splice sites
Q39926370	Human papillomavirus type 16 E2 protein transcriptionally activates the promoter of a key cellular splicing factor, SF2/ASF.
Q39762451	Human papillomavirus type 16 E5 protein inhibits hydrogen-peroxide-induced apoptosis by stimulating ubiquitin-proteasome-mediated degradation of Bax in human cervical cancer cells
Q34150408	Human papillomavirus type 16 E6 amino acid 83 variants enhance E6-mediated MAPK signaling and differentially regulate tumorigenesis by notch signaling and oncogenic Ras.
Q39606694	Human papillomavirus type 16 E6 induces cervical cancer cell migration through the p53/microRNA-23b/urokinase-type plasminogen activator pathway
Q40584427	Human papillomavirus type 16 E6 promotes retinoblastoma protein phosphorylation and cell cycle progression.
Q36581570	Human papillomavirus type 16 E6 variants in France and risk of viral persistence
Q33743745	Human papillomavirus type 16 E6* induces oxidative stress and DNA damage
Q34501316	Human papillomavirus type 16 E6/E7-specific cytotoxic T lymphocytes for adoptive immunotherapy of HPV-associated malignancies.
Q36098917	Human papillomavirus type 16 E7 oncoprotein associates with the cullin 2 ubiquitin ligase complex, which contributes to degradation of the retinoblastoma tumor suppressor
Q37393660	Human papillomavirus type 16 and 18 in primary lung cancers--a meta-analysis
Q44037011	Human papillomavirus type 16 infection may be involved in esophageal squamous cell carcinoma carcinogenesis in Chinese Kazakh patients
Q36748177	Human papillomavirus type 16 reduces the expression of microRNA-218 in cervical carcinoma cells.
Q36497960	Human papillomavirus type 16 variant analysis of E6, E7, and L1 genes and long control region in biopsy samples from cervical cancer patients in north India
Q33887322	Human papillomavirus type 16 viral load measurement as a predictor of infection clearance
Q90428210	Human papillomavirus type 18 E5 oncoprotein cooperates with E6 and E7 in promoting cell viability and invasion and in modulating the cellular redox state
Q37604419	Human papillomavirus type 26 infection causing multiple invasive squamous cell carcinomas of the fingernails in an AIDS patient under highly active antiretroviral therapy
Q39958046	Human papillomavirus type 45 E7 is a transforming protein inducing retinoblastoma protein degradation and anchorage-independent cell cycle progression.
Q37123374	Human papillomavirus type 58 genome variations and RNA expression in cervical lesions
Q36171898	Human papillomavirus type 8 E6 oncoprotein inhibits transcription of the PDZ protein syntenin-2.
Q44574224	Human papillomavirus type specific DNA and RNA persistence--implications for cervical disease progression and monitoring
Q26853556	Human papillomavirus vaccination: a case study in translational science
Q35838751	Human papillomavirus vaccine intent and uptake among female college students
Q45407529	Human papillomavirus-16 DNA methylation patterns support a causal association of the virus with oral squamous cell carcinomas
Q53275556	Human papillomavirus-16 E5 protein: oncogenic role and therapeutic value.
Q33510347	Human papillomavirus-16 E7 interacts with glutathione S-transferase P1 and enhances its role in cell survival
Q37361262	Human papillomavirus-16 and -18 in penile carcinomas: DNA methylation, chromosomal recombination and genomic variation
Q36608615	Human papillomavirus-16 is integrated in lung carcinomas: a study in Chile
Q37631295	Human papillomavirus-associated head and neck squamous cell carcinoma survival: a comparison by tumor site and initial treatment.
Q36499715	Human papillomavirus-associated increase in p16INK4A expression in penile lichen sclerosus and squamous cell carcinoma
Q45865913	Human papillomavirus-like particles mediate functional delivery of plasmid DNA to antigen presenting cells in vivo
Q38136127	Human papillomavirus: current status and issues of vaccination.
Q35601883	Human papillomaviruses activate and recruit SMC1 cohesin proteins for the differentiation-dependent life cycle through association with CTCF insulators
Q28476215	Human papillomaviruses activate the ATM DNA damage pathway for viral genome amplification upon differentiation
Q36163234	Human papillomaviruses and cell signaling
Q34208269	Human papillomaviruses and the interferon response
Q38026999	Human papillomaviruses and the specificity of PDZ domain targeting.
Q37850481	Human papillomaviruses in oral carcinoma and oral potentially malignant disorders: a systematic review.
Q38154014	Human papillomaviruses in urological malignancies: a critical assessment
Q24629203	Human papillomaviruses modulate expression of microRNA 203 upon epithelial differentiation to control levels of p63 proteins
Q37333627	Human papillomaviruses, cervical cancer and cell polarity
Q37390871	Human papillomaviruses: a growing field
Q44323958	Human telomerase gene amplification and high-risk human papillomavirus infection in women with cervical intra-epithelial neoplasia
Q34423461	Human viruses and cancer.
Q43560096	Hybrid capture 2 human papillomavirus DNA testing for women with atypical squamous cells of undetermined significance Papanicolaou results in SurePath and ThinPrep specimens
Q33533452	Hybrid capture vs. PCR screening of cervical human papilloma virus infections. Cytological and histological associations in 1270 women
Q33453988	Hypermethylation of genomic 3.3-kb repeats is frequent event in HPV-positive cervical cancer
Q41284449	Hypermutation in the E2 gene of human papillomavirus type 16 in cervical intraepithelial neoplasia.
Q35541384	Hypoxia inducible factor-1 alpha expression is increased in infected positive HPV16 DNA oral squamous cell carcinoma and positively associated with HPV16 E7 oncoprotein
Q27001095	Hypoxia-inducible factor 1 and its role in viral carcinogenesis
Q47120363	Hypoxia-inducible factor-1α activation in HPV-positive head and neck squamous cell carcinoma cell lines.
Q34556695	IGF axis and other factors in HPV-related and HPV-unrelated carcinogenesis (review).
Q34195319	IL-18, but not IL-12, induces production of IFN-γ in the immunosuppressive environment of HPV16 E7 transgenic hyperplastic skin
Q40524644	ISCOMATRIX adjuvant: an adjuvant suitable for use in anticancer vaccines
Q37438391	Identificaiton of Novel Immunogenic Human Papillomavirus Type 16 E7-Specific Epitopes Restricted to HLA-A*33;03 for Cervical Cancer Immunotherapy
Q35025360	Identification and characterization of eleven novel human gamma-papillomavirus isolates from healthy skin, found at low frequency in a normal population
Q34093276	Identification and characterization of small molecule human papillomavirus E6 inhibitors
Q47595263	Identification of E6/E7-Dependent MicroRNAs in HPV-Positive Cancer Cells.
Q38323809	Identification of a proliferation gene cluster associated with HPV E6/E7 expression level and viral DNA load in invasive cervical carcinoma
Q24672044	Identification of a third human polyomavirus
Q92472600	Identification of bovine papillomavirus type 1 and 2 from bovine anogenital fibropapillomas
Q53544703	Identification of cellular targets for the human papillomavirus E6 and E7 oncogenes by RNA interference and transcriptome analyses.
Q34578434	Identification of differentially expressed genes in HPV-positive and HPV-negative oropharyngeal squamous cell carcinomas
Q40688054	Identification of genetic variants in TNF receptor 2 which are associated with the development of cervical carcinoma
Q91599039	Identification of high-risk human papillomavirus and Rb/E2F pathway genomic alterations in mutually exclusive subsets of colorectal neuroendocrine carcinoma
Q84945841	Identification of novel immunogenic human leukocyte antigen-A 2402-binding epitopes of human papillomavirus type 16 E7 for immunotherapy against human cervical cancer
Q40210517	Identification of the FHL2 transcriptional coactivator as a new functional target of the E7 oncoprotein of human papillomavirus type 16.
Q59355953	Identification of virus-encoded microRNAs in divergent Papillomaviruses
Q34394559	Immortalization of erythroblasts by c-MYC and BCL-XL enables large-scale erythrocyte production from human pluripotent stem cells
Q89848390	Immune Response of Plasmacytoid Dendritic Cells Stimulated by Human Papillomavirus (HPV) E6 in an In Vitro System
Q36794745	Immune concept of human papillomaviruses and related antigens in local cancer milieu of human cervical neoplasia
Q46307176	Immunisation with recombinant BCG expressing the cottontail rabbit papillomavirus (CRPV) L1 gene provides protection from CRPV challenge
Q34415859	Immunization and immunotherapy for cancers involving infection by a human papillomavirus in a mouse model
Q37161653	Immunobiology of HPV and HPV vaccines
Q53902929	Immunocytochemistry in liquid-based cervical cytology: analysis of clinical use following a cross-sectional study.
Q31159398	Immunogenicity of a trivalent human papillomavirus L1 DNA-encapsidated, non-replicable baculovirus nanovaccine
Q40328917	Immunohistochemical expression of p16(INK4a) is predictive of HR-HPV infection in cervical low-grade lesions
Q35818624	Immunologic Control of Mus musculus Papillomavirus Type 1.
Q37545001	Immunological characterization of a modified vaccinia virus Ankara vector expressing the human papillomavirus 16 E1 protein
Q35603131	Immunosuppressive tumor microenvironment in cervical cancer patients
Q37773267	Immunotherapeutic polyoma and human papilloma virus-like particles
Q34033763	Immunotherapy for cervical cancer: Research status and clinical potential
Q36239661	Immunotherapy for gynaecological malignancies.
Q26744094	Immunotherapy for human papillomavirus-associated disease and cervical cancer: review of clinical and translational research
Q34479115	Impact of HPV in Oropharyngeal Cancer
Q93038299	Impact of family physicians on cervical cancer screening: cross-sectional questionnaire-based survey in a region of southern Poland
Q33591582	Impact of inhibitors and L2 antibodies upon the infectivity of diverse alpha and beta human papillomavirus types
Q40220618	Impact of viral and host DNA methylations on HPV16-related cervical cancer pathogenesis
Q64107156	Impacts of single nucleotide polymorphisms in three microRNAs (miR-146a, miR-196a2 and miR-499) on the susceptibility to cervical cancer among Indian women
Q92030460	Importance of the immune system in head and neck cancer
Q34397856	Improving therapeutic HPV peptide-based vaccine potency by enhancing CD4+ T help and dendritic cell activation
Q37391594	In Vitro and In Vivo Synergistic Therapeutic Effect of Cisplatin with Human Papillomavirus16 E6/E7 CRISPR/Cas9 on Cervical Cancer Cell Line
Q95383249	In inverted papillomas HPV more likely represents incidental colonization than an etiological factor
Q79673935	In silico analysis of protein neoplastic biomarkers for cervix and uterine cancer
Q30661799	In silico mechanistic analysis of IRF3 inactivation and high-risk HPV E6 species-dependent drug response
Q33654853	In vivo and in vitro studies suggest a possible involvement of HPV infection in the early stage of breast carcinogenesis via APOBEC3B induction
Q36539864	Increase of integration events and infection loads of human papillomavirus type 52 with lesion severity from low-grade cervical lesion to invasive cancer.
Q36165287	Increased Growth of a Newly Established Mouse Epithelial Cell Line Transformed with HPV-16 E7 in Diabetic Mice
Q35824966	Increased RIPK4 expression is associated with progression and poor prognosis in cervical squamous cell carcinoma patients
Q37422479	Increased incidence of squamous cell carcinomas in Mastomys natalensis papillomavirus E6 transgenic mice during two-stage skin carcinogenesis
Q38999029	Increased sensitivity of HPV-positive head and neck cancer cell lines to x-irradiation ± Cisplatin due to decreased expression of E6 and E7 oncoproteins and enhanced apoptosis
Q36072514	Independent Pre-Transplant Recipient Cancer Risk Factors after Kidney Transplantation and the Utility of G-Chart Analysis for Clinical Process Control.
Q37428060	Individual karyotypes at the origins of cervical carcinomas
Q43115659	Indoleamine 2,3-dioxygenase expression predicts impaired survival of invasive cervical cancer patients treated with radical hysterectomy
Q39777974	Inducible heat shock protein 70 enhances HPV31 viral genome replication and virion production during the differentiation-dependent life cycle in human keratinocytes
Q40088428	Induction of MHC class I molecule cell surface expression and epigenetic activation of antigen-processing machinery components in a murine model for human papilloma virus 16-associated tumours
Q39971029	Induction of SiHa cells apoptosis by nanometer realgar suspension and its mechanism
Q40367504	Induction of dormancy in hypoxic human papillomavirus-positive cancer cells.
Q37421689	Induction of promyelocytic leukemia (PML) oncogenic domains (PODs) by papillomavirus
Q37965915	Inflammation and cancer: a comparative view
Q37444502	Influence of IL-6, IL-8, and TGF-β1 gene polymorphisms on the risk of human papillomavirus-infection in women from Pernambuco, Brazil
Q36970255	Influence of oxidation and multimerization on the immunogenicity of a thioredoxin-l2 prophylactic papillomavirus vaccine
Q34708628	Influence of the viral regulatory region on tumor induction by simian virus 40 in hamsters
Q36137235	Influenza Transmission in the Mother-Infant Dyad Leads to Severe Disease, Mammary Gland Infection, and Pathogenesis by Regulating Host Responses
Q24303964	Inhibition of Bax activity is crucial for the antiapoptotic function of the human papillomavirus E6 oncoprotein
Q34142823	Inhibition of E2 binding to Brd4 enhances viral genome loss and phenotypic reversion of bovine papillomavirus-transformed cells.
Q27313997	Inhibition of c-Abl kinase activity renders cancer cells highly sensitive to mitoxantrone
Q54594486	Inhibition of cervical cancer cell growth in vitro and in vivo with lentiviral-vector delivered short hairpin RNA targeting human papillomavirus E6 and E7 oncogenes.
Q38763356	Inhibition of endoplasmic reticulum (ER) stress sensors sensitizes cancer stem-like cells to ER stress-mediated apoptosis
Q34770731	Inhibition of human papilloma virus E2 DNA binding protein by covalently linked polyamides
Q37743775	Inhibition of human papillomavirus type 16 E7 phosphorylation by the S100 MRP-8/14 protein complex
Q39671503	Inhibition of nuclear entry of HPV16 pseudovirus-packaged DNA by an anti-HPV16 L2 neutralizing antibody
Q57475463	Innate immunity and HPV: friends or foes
Q34544154	Innovative DNA vaccine for human papillomavirus (HPV)-associated head and neck cancer
Q34635004	Integrated omic analysis of oropharyngeal carcinomas reveals human papillomavirus (HPV)-dependent regulation of the activator protein 1 (AP-1) pathway
Q84581966	Integration of human papillomavirus correlates with high levels of viral oncogene transcripts in cervical carcinogenesis
Q33967257	Integration of interferon-alpha/beta signalling to p53 responses in tumour suppression and antiviral defence.
Q81165889	Integration of the HPV16 genome does not invariably result in high levels of viral oncogene transcripts
Q24322023	Integrative genomics analysis of chromosome 5p gain in cervical cancer reveals target over-expressed genes, including Drosha
Q33290324	Inter-laboratory validation of PCR-based HPV detection in pathology specimens
Q62488559	Interaction between inflammation and angiogenesis during different stages of cervical carcinogenesis
Q30764287	Interaction of L2 with beta-actin directs intracellular transport of papillomavirus and infection
Q36138481	Interaction of the Human Papillomavirus E6 Oncoprotein with Sorting Nexin 27 Modulates Endocytic Cargo Transport Pathways
Q28258520	Interaction of the bovine papillomavirus E2 protein with Brd4 tethers the viral DNA to host mitotic chromosomes
Q41862182	Interaction of the papillomavirus E8--E2C protein with the cellular CHD6 protein contributes to transcriptional repression.
Q45277665	Interactions of the cellular CCAAT displacement protein and human papillomavirus E2 protein with the viral origin of replication can regulate DNA replication
Q33850340	Interactome analysis of gene expression profiles of cervical cancer reveals dysregulated mitotic gene clusters
Q40185102	Interference with energy metabolism by 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside induces HPV suppression in cervical carcinoma cells and apoptosis in the absence of LKB1.
Q37220168	Interleukin-1 beta-511 polymorphism and risk of cervical cancer
Q61796337	Interplay among Vaginal Microbiome, Immune Response and Sexually Transmitted Viral Infections
Q38198724	Interventions to improve cervical cancer screening uptake amongst young women: a systematic review
Q35685208	Intracellular Analysis of the Interaction between the Human Papillomavirus Type 16 E6 Oncoprotein and Inhibitory Peptides
Q36719344	Intraductal papilloma of the breast in association with preoncogenic gene of breast cancer
Q35812239	Intravaginal HPV DNA vaccination with electroporation induces local CD8+ T-cell immune responses and antitumor effects against cervicovaginal tumors
Q35632957	Intrinsic disorder and functional proteomics
Q42246544	Investigation of p16(INK4a) as a prognostic biomarker in oral epithelial dysplasia
Q39868210	Involvement of NF-kappaB and AP-1 in COX-2 upregulation by human papillomavirus 16 E5 oncoprotein.
Q34499329	Involvement of aryl hydrocarbon receptor signaling in the development of small cell lung cancer induced by HPV E6/E7 oncoproteins
Q36578125	Is human papillomavirus involved in laryngeal neuroendocrine carcinoma?
Q38262681	Is there a higher prevalence of human papillomavirus infection in Chinese laryngeal cancer patients? A systematic review and meta-analysis
Q34450609	Isolation of three novel rat and mouse papillomaviruses and their genomic characterization
Q24634312	JC virus in the pathogenesis of colorectal cancer, an etiological agent or another component in a multistep process?
Q55384977	Jagged-1 induced molecular alterations in HPV associated invasive squamous cell and adenocarcinoma of the human uterine cervix.
Q46425875	KIT activation in uterine cervix adenosquamous carcinomas by KIT/SCF autocrine/paracrine stimulation loops.
Q44022501	KLF5 promotes cervical cancer proliferation, migration and invasion in a manner partly dependent on TNFRSF11a expression
Q93015925	Kaempferia parviflora Extract Inhibits STAT3 Activation and Interleukin-6 Production in HeLa Cervical Cancer Cells
Q37411628	Karyopherin beta3: a new cellular target for the HPV-16 E5 oncoprotein
Q36954856	Kinase requirements in human cells: II. Genetic interaction screens identify kinase requirements following HPV16 E7 expression in cancer cells
Q34005003	Kinase requirements in human cells: V. Synthetic lethal interactions between p53 and the protein kinases SGK2 and PAK3
Q90114904	Knowledge about cervical cancer and HPV immunization dropout rate among Brazilian adolescent girls and their guardians
Q45385830	Knowledge differences between male and female university students about human papillomavirus (HPV) and cervical cancer: Implications for health strategies and vaccination
Q37401500	Koilocytes indicate a role for human papilloma virus in breast cancer
Q24656125	Koilocytosis: a cooperative interaction between the human papillomavirus E5 and E6 oncoproteins
Q39428352	Krüppel-like factor 4 functions as a tumor suppressor in cervical carcinoma
Q38690062	Kv10.1 K(+) channel: from physiology to cancer.
Q37164879	L2, the minor capsid protein of papillomavirus
Q40124109	LALF32-51 -E7, a HPV-16 therapeutic vaccine candidate, forms protein body-like structures when expressed in Nicotiana benthamiana leaves
Q40098243	LINC01101 and LINC00277 expression levels as novel factors in HPV-induced cervical neoplasia
Q36311573	Laboratory and clinical aspects of human papillomavirus testing
Q64987709	Lack of association between methylenetetrahydrofolate reductase C677T polymorphism, HPV infection and cervical intraepithelial neoplasia in Brazilian women.
Q41655215	Lack of association between serum 25-hydroxyvitamin D levels and cervical human papillomavirus infection in systemic lupus erythematosus.
Q37565343	Lack of association between the FAS/FASL polymorphisms and cervical cancer risk: A meta-analysis
Q37362882	Lack of correlation between p53 codon 72 polymorphism and anal cancer risk
Q36414507	Lack of methylation in the upstream region of human papillomavirus type 6 from aerodigestive tract papillomas
Q37348474	Large-scale analysis of protein expression changes in human keratinocytes immortalized by human papilloma virus type 16 E6 and E7 oncogenes
Q90101281	Laryngeal Dysplasia: Persisting Dilemmas, Disagreements and Unsolved Problems-A Short Review
Q33460823	Laser capture microdissection of cervical human papillomavirus infections: copy number of the virus in cancerous and normal tissue and heterogeneous DNA methylation
Q35689096	Liquid-based urine cytology as a tool for detection of human papillomavirus, Mycoplasma spp., and Ureaplasma spp. in men.
Q35838127	Lm-LLO-Based Immunotherapies and HPV-Associated Disease
Q64084230	LncRNA NEF inhibits migration and invasion of HPV-negative cervical squamous cell carcinoma by inhibiting TGF-β pathway
Q54211989	LncRNA PVT1 promotes the growth of HPV positive and negative cervical squamous cell carcinoma by inhibiting TGF-β1.
Q47441530	Long-term persistence of human papillomavirus in the skin of the glans penis of elderly men above 80 years of age.
Q54968953	Long-term toxicity, pharmacokinetics and immune effects of a recombinant adenovirus vaccine expressing human papillomavirus 16 E6 and E7 proteins (HPV16 E6E7-Ad5 Vac) in primates.
Q53363191	Loss of net as repressor leads to constitutive increased c-fos transcription in cervical cancer cells.
Q53515349	Loss of p53 or p73 in human papillomavirus type 38 E6 and E7 transgenic mice partially restores the UV-activated cell cycle checkpoints.
Q33290438	Loss of robustness and addiction to IGF1 during early keratinocyte transformation by human Papilloma virus 16
Q37175037	Loss of the cell polarity determinant human Discs-large is a novel molecular marker of nodal involvement and poor prognosis in endometrial cancer
Q41810748	Low risk HPV-E6 traps p53 in the cytoplasm and induces p53-dependent apoptosis
Q33819744	Low- and high-risk human papillomavirus E7 proteins regulate p130 differently
Q37374278	Lymph node-targeted immunotherapy mediates potent immunity resulting in regression of isolated or metastatic human papillomavirus-transformed tumors.
Q40494871	MG132 plus apoptosis antigen-1 (APO-1) antibody cooperate to restore p53 activity inducing autophagy and p53-dependent apoptosis in HPV16 E6-expressing keratinocytes
Q41206969	MPG-based nanoparticle: An efficient delivery system for enhancing the potency of DNA vaccine expressing HPV16E7.
Q38837737	Management of high-risk HPV-positive women for detection of cervical (pre)cancer.
Q39003287	Manipulation of the innate immune response by human papillomaviruses
Q39066387	Mapping of betapapillomavirus human papillomavirus 5 transcription and characterization of viral-genome replication function
Q42477461	Marginal periodontium as a potential reservoir of human papillomavirus in oral mucosa
Q26799320	Mate-Pair Sequencing as a Powerful Clinical Tool for the Characterization of Cancers with a DNA Viral Etiology
Q36745693	Maternal transmission of human papillomavirus in retinoblastoma: A possible route of transfer
Q27025941	Matrix and backstage: cellular substrates for viral vaccines
Q37111551	MePR: a novel human mesenchymal progenitor model with characteristics of pluripotency.
Q35563731	Mechanical characterization of cervical squamous carcinoma cells by atomic force microscopy at nanoscale
Q35642280	Mechanisms of genomic instability in human cancer: insights from studies with human papillomavirus oncoproteins
Q35915935	Mechanisms of human papillomavirus-induced oncogenesis.
Q57064814	Mechanisms of persistence by small DNA tumor viruses
Q27002467	Mechanisms of virus immune evasion lead to development from chronic inflammation to cancer formation associated with human papillomavirus infection
Q33755840	Mechanistic insights into ADXS11-001 human papillomavirus-associated cancer immunotherapy
Q50983395	Meta-analysis of microRNA expression profiling studies in human cervical cancer.
Q34011808	Meta-analysis of the impact of human papillomavirus (HPV) on cancer risk and overall survival in head and neck squamous cell carcinomas (HNSCC).
Q26999877	Metagenomics: A new horizon in cancer research
Q36372288	Methylation of Cervical Neoplastic Cells Infected With Human Papillomavirus 16
Q41612137	Methylation of HPV and a tumor suppressor gene reveals anal cancer and precursor lesions
Q50053585	Methylation of the L1 gene and integration of human papillomavirus 16 and 18 in cervical carcinoma and premalignant lesions
Q53278101	Methylation status of the E2 binding sites of HPV16 in cervical lesions determined with the Luminex® xMAP™ system.
Q42186892	Methylation-mediated repression of PRDM14 contributes to apoptosis evasion in HPV-positive cancers.
Q39426030	MicroRNA-133b is a key promoter of cervical carcinoma development through the activation of the ERK and AKT1 pathways
Q39987020	MicroRNA-187 inhibits tumor growth and invasion by directly targeting CD276 in colorectal cancer
Q57788723	MicroRNA-206 suppresses proliferation and predicts poor prognosis of HR-HPV-positive cervical cancer cells by targeting G6PD
Q34107306	MicroRNA-34a suppresses invasion through downregulation of Notch1 and Jagged1 in cervical carcinoma and choriocarcinoma cells.
Q38212798	MicroRNAs in cervical cancer: evidences for a miRNA profile deregulated by HPV and its impact on radio-resistance.
Q27890382	Microbe Hunting
Q36648701	Minichromosome maintenance (Mcm) proteins, cyclin B1 and D1, phosphohistone H3 and in situ DNA replication for functional analysis of vulval intraepithelial neoplasia
Q30665906	Mining RNA-seq data for infections and contaminations
Q35135678	Minireview: The roles of small RNA pathways in reproductive medicine
Q35665790	Minor Cytological Abnormalities and up to 7-Year Risk for Subsequent High-Grade Lesions by HPV Type
Q47322093	Minor capsid protein L2 polytope induces broad protection against oncogenic and mucosal human papillomaviruses
Q36226733	Mitochondria as functional targets of proteins coded by human tumor viruses
Q40829202	MmuPV1 infection and tumor development of T cell-deficient mice is prevented by passively transferred hyperimmune sera from normal congenic mice immunized with MmuPV1 virus-like particles (VLPs).
Q39382681	Modeling and molecular dynamics of the intrinsically disordered e7 proteins from high- and low-risk types of human papillomavirus.
Q38789949	Modulation of basal cell fate during productive and transforming HPV-16 infection is mediated by progressive E6-driven depletion of Notch.
Q38270264	Molecular Basis of Pterygium Development.
Q37236208	Molecular Signature of HPV-Induced Carcinogenesis: pRb, p53 and Gene Expression Profiling
Q36805303	Molecular and genetic pathways in penile cancer
Q33798618	Molecular and serologic markers of HPV 16 infection are associated with local recurrence in patients with oral cavity squamous cell carcinoma.
Q36862117	Molecular biology of cervical cancer
Q38115352	Molecular biomarkers in cervical cancer diagnosis: a critical appraisal.
Q36457679	Molecular diagnosis and phylogenetic analysis of human papillomavirus type-16 from suspected patients in Pakistan
Q37133594	Molecular epidemiology of human papillomavirus
Q35122647	Molecular interactions of ‘high risk’ human papillomaviruses E6 and E7 oncoproteins: implications for tumour progression
Q58694941	Molecular iodine inhibits the expression of stemness markers on cancer stem-like cells of established cell lines derived from cervical cancer
Q35560090	Molecular markers in cervical cytology
Q40632513	Molecular markers in cutaneous squamous cell carcinoma
Q28280924	Molecular mechanism behind rotavirus NSP1-mediated PI3 kinase activation: interaction between NSP1 and the p85 subunit of PI3 kinase
Q36303426	Molecular mechanisms of human papillomavirus-induced carcinogenesis.
Q40589278	Molecular pathways executing the "trophic sentinel" response in HPV-16 E7-expressing normal human diploid fibroblasts upon growth factor deprivation
Q24653706	Molecular profiling of cervical cancer progression
Q37189400	Molecular prognostic factors in penile cancer
Q42198809	Molecular variants of human papilloma virus 16 E2, E4, E5, E6 and E7 genes associated with cervical neoplasia in Romanian patients
Q38719253	Monitoring HPV-16 E7 phosphorylation events
Q37808256	Monitoring of human papillomavirus vaccination.
Q90221026	Mouse Tumor-Bearing Models as Preclinical Study Platforms for Oral Squamous Cell Carcinoma
Q40327423	Mucosal alpha-papillomaviruses are not associated with esophageal squamous cell carcinomas: Lack of mechanistic evidence from South Africa, China and Iran and from a world-wide meta-analysis
Q24559793	Mucosal human papillomaviruses encode four different E5 proteins whose chemistry and phylogeny correlate with malignant or benign growth
Q37776652	Multifaceted polo-like kinases: drug targets and antitargets for cancer therapy
Q56900811	Multifactorial etiology of cervical cancer: a hypothesis
Q33592653	Multiple ASF/SF2 sites in the human papillomavirus type 16 (HPV-16) E4-coding region promote splicing to the most commonly used 3'-splice site on the HPV-16 genome
Q36748493	Multiple biomarkers in molecular oncology. I. Molecular diagnostics applications in cervical cancer detection
Q40208771	Multiple interference of the human papillomavirus-16 E7 oncoprotein with the functional role of the metastasis suppressor Nm23-H1 protein.
Q42690491	Multiple oncogenic viruses are present in human breast tissues before development of virus associated breast cancer
Q45362511	Multiple types of high-risk human papilloma virus in the lower genital tract of a female kidney recipient: a case report
Q50107195	Mutational signatures and chromosome alteration profiles of squamous cell carcinomas of the vulva
Q38061252	Mutations of the TP53 gene in adenocarcinoma and squamous cell carcinoma of the cervix: a systematic review
Q40691202	NF-Y loss triggers p53 stabilization and apoptosis in HPV18-positive cells by affecting E6 transcription.
Q37093403	NFI-Ski interactions mediate transforming growth factor beta modulation of human papillomavirus type 16 early gene expression.
Q41430113	NFKB1/NFKBIa polymorphisms are associated with the progression of cervical carcinoma in HPV-infected postmenopausal women from rural area
Q39426890	NRIP enhances HPV gene expression via interaction with either GR or E2.
Q35775296	Nanomechanical clues from morphologically normal cervical squamous cells could improve cervical cancer screening
Q37274692	Nanoparticles for transcutaneous vaccination
Q38370785	Nanotechnology in the management of cervical cancer
Q60953504	Natural Compound Modulates the Cervical Cancer Microenvironment-A Pharmacophore Guided Molecular Modelling Approaches
Q64274770	Natural history of human papillomavirus and vaccinations in men: A literature review
Q45338163	Natural variants in the major neutralizing epitope of human papillomavirus minor capsid protein L2.
Q36695105	Negative human papillomavirus testing in normal smears selects a population at low risk for developing high-grade cervical lesions.
Q28072213	New Biomedical Technologies and Strategies for Prevention of HIV and Other Sexually Transmitted Infections
Q38015390	New Concepts for Translational Head and Neck Oncology: Lessons from HPV-Related Oropharyngeal Squamous Cell Carcinomas
Q58700402	New Insights in the Pathogenesis of HPV Infection and the Associated Carcinogenic Processes: The Role of Chronic Inflammation and Oxidative Stress
Q81068254	New aspects of vulvar cancer: changes in localization and age of onset
Q33620876	New generic primer system targeting mucosal/genital and cutaneous human papillomaviruses leads to the characterization of HPV 115, a novel Beta-papillomavirus species 3
Q34477924	New viral vaccines.
Q37702829	Next generation sequencing and its applications in HPV-associated cancers
Q36714819	Next-Generation Sequencing-Based HPV Genotyping Assay Validated in Formalin-Fixed, Paraffin-Embedded Oropharyngeal and Cervical Cancer Specimens
Q37943790	Next-generation treatment strategies for human papillomavirus-related head and neck squamous cell carcinoma: where do we go?
Q36363313	Nine complete genome sequences of cutaneous human papillomavirus genotypes isolated from healthy skin of individuals living in rural He Nan province, China
Q36893209	Nitric oxide and cancer: a review
Q37289125	Nitric oxide induces early viral transcription coincident with increased DNA damage and mutation rates in human papillomavirus-infected cells.
Q36540813	No Association of Matrix Metalloproteinase [MMP]-2 (-735C > T) and Tissue Inhibitor of Metalloproteinase [TIMP]-2 (-418G > C) Gene Polymorphisms with Cervical Cancer Susceptibility
Q33433442	Nobel price for vaccination against cervical cancer: current data and guidelines
Q47096307	Non-coding RNAs profiling in head and neck cancers.
Q34982617	Nonconserved lysine residues attenuate the biological function of the low-risk human papillomavirus E7 protein
Q29542551	Notch1 regulates the functional contribution of RhoC to cervical carcinoma progression
Q33710443	Novel Betapapillomavirus Associated With Hand and Foot Papillomas in a Cynomolgus Macaque
Q38824331	Novel MicroRNA signatures in HPV-mediated cervical carcinogenesis in Indian women
Q45042849	Novel human papilloma virus (HPV) genotypes in children with recurrent respiratory papillomatosis
Q47131449	Novel insights into epigenetic drivers of oropharyngeal squamous cell carcinoma: role of HPV and lifestyle factors
Q36607397	Novel methods to treat and prevent human papillomavirus infection
Q54335305	Novel multiplexed genotyping of human papillomavirus using a VeraCode-allele-specific primer extension method.
Q45045503	Novel oligomannose liposome-DNA complex DNA vaccination efficiently evokes anti-HPV E6 and E7 CTL responses
Q39024774	Obesity and Cancer Mechanisms: Tumor Microenvironment and Inflammation
Q37316158	Oncogenic activities of human papillomaviruses
Q61815007	Oncogenic comparison of human papillomavirus type 58 E7 variants
Q35113442	Oncogenic human papillomaviruses activate the tumor-associated lens epithelial-derived growth factor (LEDGF) gene
Q37556468	Oncogenic processes
Q54263650	Opportunities and challenges for human papillomavirus vaccination in cancer.
Q39817550	Optimal induction of HPV DNA vaccine-induced CD8+ T cell responses and therapeutic antitumor effect by antigen engineering and electroporation
Q59361142	Optimization of human papillomavirus (HPV) type 16 E7-expressing lactobacillus-based vaccine for induction of mucosal E7-specific IFNγ-producing cells
Q34576677	Optimization of multimeric human papillomavirus L2 vaccines
Q39933426	Oral HPV prevalence in women positive for cervical HPV infection and their sexual partners: a German screening study
Q26740061	Oral environment and cancer
Q36916077	Oral lichen planus in thai patients has a low prevalence of human papillomavirus
Q58766185	Oral manifestations of human papillomavirus infections
Q41725510	Oral vaccination against HPV E7 for treatment of cervical intraepithelial neoplasia grade 3 (CIN3) elicits E7-specific mucosal immunity in the cervix of CIN3 patients
Q54332193	Overexpression of RhoA promotes the proliferation and migration of cervical cancer cells.
Q47864539	Overexpression of STAT3 in HPV-mediated cervical cancer in a north Indian population
Q43572871	Overexpression of Y-box binding protein-1 in cervical cancer and its association with the pathological response rate to chemoradiotherapy
Q47606379	Overview of Infectious Causes of Human Cancers
Q40205373	Ovis aries Papillomavirus 3 in Ovine Cutaneous Squamous Cell Carcinoma.
Q36807150	Oxidative stress and HPV carcinogenesis.
Q34217919	Oxidative stress in HPV-driven viral carcinogenesis: redox proteomics analysis of HPV-16 dysplastic and neoplastic tissues
Q59806695	Oxidative stress: therapeutic approaches for cervical cancer treatment
Q51755668	P21 Cip1/WAF1 expression is strongly associated with HPV-positive tonsillar carcinoma and a favorable prognosis.
Q40957506	P2X(5) and P2X(7) receptors in human warts and CIN-612 organotypic raft cultures of human papillomavirus infected keratinocytes
Q36473565	P53 represses human papillomavirus type 16 DNA replication via the viral E2 protein
Q34279992	PARP-1 Val762Ala polymorphism is associated with risk of cervical carcinoma
Q59357945	PD-1/PD-L1 immune checkpoint inhibitors in advanced cervical cancer
Q40208391	PDCD1 (PD-1) promoter methylation predicts outcome in head and neck squamous cell carcinoma patients
Q90616789	PDZ Domain-Containing Protein NHERF-2 Is a Novel Target of Human Papillomavirus 16 (HPV-16) and HPV-18
Q91783484	PI3K/AKT/mTOR Signaling Regulates the Virus/Host Cell Crosstalk in HPV-Positive Cervical Cancer Cells
Q47368506	PLK4: a link between centriole biogenesis and cancer
Q39861475	Paclitaxel combined with siRNA targeting HPV16 oncogenes improves cytotoxicity for cervical carcinoma
Q42376348	Paediatric Virology as a new educational initiative: An interview with Nobelist Professor of Virology Harald zur Hausen
Q37697706	Paediatric Virology: A rapidly increasing educational challenge.
Q92668951	Paediatric virology and human papillomaviruses: An update
Q35642759	Papillomavirus E5: the smallest oncoprotein with many functions
Q33788885	Papillomavirus capsid mutation to escape dendritic cell-dependent innate immunity in cervical cancer
Q34178325	Papillomavirus infection requires gamma secretase
Q33729502	Papillomavirus interaction with cellular chromatin
Q33614425	Papillomavirus prophylactic vaccines: established successes, new approaches
Q38109267	Papillomavirus transcripts and posttranscriptional regulation
Q24563952	Papillomavirus-mediated neoplastic progression is associated with reciprocal changes in JAGGED1 and manic fringe expression linked to notch activation
Q36337998	Papillomaviruses as targets for cancer gene therapy
Q37208883	Papillomaviruses--to vaccination and beyond
Q33329537	Parallels between pathogens and gluten peptides in celiac sprue
Q34349416	Pathogenesis of human papillomaviruses in differentiating epithelia
Q30491371	Pathological manifestations of feline immunodeficiency virus (FIV) infection in wild African lions
Q64264674	Pathological mechanisms of laryngeal papillomatosis based on laryngeal epithelial characteristics
Q37715406	Pathology and epidemiology of HPV infection in females
Q59065207	Pathology: Three questions
Q45353082	Patterns of cervical coinfection with multiple human papilloma virus types in a screening population in Denmark
Q42657502	Patterns of nucleotide difference in overlapping and non-overlapping reading frames of papillomavirus genomes
Q33757149	Pembrolizumab in cervical cancer: latest evidence and clinical usefulness
Q34012647	Penile cancer: epidemiology, pathogenesis and prevention
Q37191617	Performance of a polymer-based DNA chip platform in detection and genotyping of human papillomavirus in clinical samples
Q37302072	Performance of human papillomavirus DNA and mRNA testing strategies for women with and without cervical neoplasia
Q39177983	Performance of mRNA- and DNA-based high-risk human papillomavirus assays in detection of high-grade cervical lesions
Q34465288	Pericentromeric regions are refractory to prompt repair after replication stress-induced breakage in HPV16 E6E7-expressing epithelial cells.
Q47779516	Persistence and load of high-risk HPV are predictors for development of high-grade cervical lesions: a longitudinal French cohort study
Q34427760	Persistence of high-grade cervical dysplasia and cervical cancer requires the continuous expression of the human papillomavirus type 16 E7 oncogene
Q92080357	Persistence of human papillomavirus 16, 18 and 52 variants in Inuit women from Northern Quebec, Canada
Q41834631	Persistence or clearance of human papillomavirus infections in women in Ouro Preto, Brazil
Q34011494	Perspectives for preventive and therapeutic HPV vaccines
Q28069272	Perspectives for therapeutic HPV vaccine development
Q44386104	Phenylbutyrate inhibits growth of cervical carcinoma cells independent of HPV type and copy number
Q42439942	Phosphorylated S6 as an immunohistochemical biomarker of vulvar intraepithelial neoplasia
Q93161915	Phosphorylation of Human Papillomavirus Type 16 L2 Contributes to Efficient Virus Infectious Entry
Q90740964	Phylogeny and Classification of Human Papillomavirus (HPV)16 and HPV18 Variants Based on E6 and L1 genes in Tunisian Women with Cervical Lesions
Q80155400	Phylogeny and evolution of papillomaviruses based on the E1 and E2 proteins
Q37983418	Plant-derived vaccines: an approach for affordable vaccines against cervical cancer
Q35967764	Pleconaril--an advance in the treatment of enteroviral infection in immuno-compromised patients
Q47689233	Polymorphisms in HPV E6/E7 protein interacted genes and risk of cervical cancer in Chinese women: a case-control analysis
Q40021164	Polypyrimidine tract binding protein induces human papillomavirus type 16 late gene expression by interfering with splicing inhibitory elements at the major late 5' splice site, SD3632
Q90076375	Positive staining of the immunoligand B7-H6 in abnormal/transformed keratinocytes consistently accompanies the progression of cervical cancer
Q34916951	Post-translational control of IL-1β via the human papillomavirus type 16 E6 oncoprotein: a novel mechanism of innate immune escape mediated by the E3-ubiquitin ligase E6-AP and p53.
Q57138571	Potent therapeutic efficacy of an alphavirus replicon DNA vaccine expressing human papilloma virus E6 and E7 antigens
Q33575647	Potential anti-HPV and related cancer agents from marine resources: an overview
Q35588988	Potential of telomerase expression and activity in cervical specimens as a diagnostic tool
Q64452799	Precancerous Lesions of Squamous Cell Carcinoma of the Cervix: Squamous Dysplasia
Q35702897	Precise Classification of Cervical Carcinomas Combined with Somatic Mutation Profiling Contributes to Predicting Disease Outcome.
Q39796733	Preclinical development of highly effective and safe DNA vaccines directed against HPV 16 E6 and E7.
Q42835249	Preclinical safety evaluation of DNA vaccines encoding modified HPV16 E6 and E7.
Q54414251	Predicting the progression of cervical precursor lesions by human papillomavirus genotyping: A prospective cohort study
Q43608671	Prediction of local recurrence in cervical cancer by a Cox model comprised of lymph node status, lymph-vascular space invasion, and intratumoral Th17 cell-infiltration
Q44937898	Prediction of outcome in patients with low-grade squamous intraepithelial lesions by fluorescence in situ hybridization analysis of human papillomavirus, TERC, and MYC.
Q35175783	Preferential recruitment of Th17 cells to cervical cancer via CCR6-CCL20 pathway
Q34569181	Presence of E6 and E7 mRNA from human papillomavirus types 16, 18, 31, 33, and 45 in the majority of cervical carcinomas
Q44817366	Presence of human papillomaviruses and p16 expression in hypopharyngeal cancer
Q24676303	Presence of mouse mammary tumour-like virus gene sequences may be associated with morphology of specific human breast cancer
Q24796364	Presence of papillomavirus sequences in condylomatous lesions of the mamillae and in invasive carcinoma of the breast
Q91922934	Prevalence and Distribution of Human Papillomavirus Genotypes Among Women in Kinshasa, The Democratic Republic of the Congo
Q58579986	Prevalence and Genotype Distribution of Human Papillomavirus in Invasive Cervical Cancer, Cervical Intraepithelial Neoplasia, and Asymptomatic Women in Southeast China
Q51578981	Prevalence and distribution of human papillomavirus findings in swab specimens from gynaecology clinics of the east coast of Spain.
Q34411782	Prevalence and distribution of human papillomavirus infection in Korean women as determined by restriction fragment mass polymorphism assay
Q36995429	Prevalence and genetic variability in capsid L1 gene of rare human papillomaviruses (HPV) found in cervical lesions of women from North-East Brazil.
Q33963437	Prevalence and genotyping of high risk human papillomavirus in cervical cancer samples from Punjab, Pakistan
Q93002391	Prevalence of HPV Genotypes in South Europe: Comparisons between an Italian and a Turkish Unvaccinated Population
Q42200747	Prevalence of HPV and variation of HPV 16/HPV 18 E6/E7 genes in cervical cancer in women in South West China
Q58995266	Prevalence of HPV in Adolescents Virgins and Sexually Active at a University Hospital in the City of Rio de Janeiro, Brazil
Q38658075	Prevalence of Human Papillomavirus Infection in Breast Cancer Cells from Thai Women
Q36373745	Prevalence of high-risk human papillomavirus cervical infection in female kidney graft recipients: an observational study
Q38137191	Prevalence of human papillomavirus in epithelial ovarian cancer tissue. A meta-analysis of observational studies.
Q49707769	Prevalence of human papillomavirus infection among Iranian women using COBAS HPV DNA testing
Q49281213	Prevalence of human papillomavirus infection among women from quilombo communities in northeastern Brazil.
Q39313728	Prevalence of human papillomavirus infection among women in rural Nepal.
Q36625605	Prevalence of human papillomavirus infection in Argentinean women attending two different hospitals prior to the implementation of the National Vaccination Program
Q57216236	Prevalence of human papillomavirus infection in women in Busan, South Korea
Q41138773	Prevalence of human papillomavirus types in cervical cancerous and precancerous lesions of Ecuadorian women
Q37839449	Prevalence of microorganisms co-infections in human papillomaviruses infected women in Northern China
Q52585506	Prevalence of mucosal and cutaneous human papillomavirus in Moroccan breast cancer.
Q54440816	Prevalence, evolution, and features of infection with human papillomavirus: a 15-year longitudinal study of routine screening of a women population in the north of Spain.
Q45960889	Prevalence, genotyping, and correlates of anogenital HPV infection in a population-based sample of women in Puerto Rico.
Q43247256	Prevalence, morphology, and prognosis of human papillomavirus in tonsillar cancer
Q35623323	Preventative and therapeutic vaccines for cervical cancer
Q37428887	Prevention and treatment of cervical cancer in mice using estrogen receptor antagonists
Q34762053	Prevention of cancer by prophylactic human papillomavirus vaccines
Q38123205	Prevention, identification and treatment of vulvar squamous (pre)malignancies: a review focusing on quality of care
Q37177735	Primary cervical cancer screening with an HPV mRNA test: a prospective cohort study
Q36847922	Primary prevention and vaccination for penile cancer
Q37780346	Principles of vaccine design-Lessons from nature
Q36235644	Production of Polyclonal Antibody to the HPV58 E7 Protein and Its Detection in Cervical Cancer
Q35802720	Production of human papillomavirus type 16 virus-like particles in transgenic plants
Q33879132	Production of infectious human papillomavirus independently of viral replication and epithelial cell differentiation
Q34717051	Productive infection of bovine papillomavirus type 2 in the urothelial cells of naturally occurring urinary bladder tumors in cattle and water buffaloes
Q37275914	Progesterone signaling inhibits cervical carcinogenesis in mice
Q37665239	Prognostic impact of the expression of Wnt-signaling proteins in cervical carcinoma FIGO stage I-IV treated with radiotherapy or chemoradiotherapy
Q47128634	Prognostic relevance of human papillomavirus infection in anal squamous cell carcinoma: analysis of the national cancer data base
Q81568998	Prognostic significance of high-risk HPV status in advanced cervical cancers and pelvic lymph nodes
Q37426794	Prognostic significance of immunohistochemical phenotypes in patients treated for high-grade cervical intraepithelial neoplasia
Q99405226	Prognostic significance of negative conversion of high-risk Human Papillomavirus DNA after treatment in Cervical Cancer patients
Q34133777	Prognostic significance of overexpressed p16INK4a in patients with cervical cancer: a meta-analysis
Q37723553	Prognostic value of DNA and mRNA e6/e7 of human papillomavirus in the evolution of cervical intraepithelial neoplasia grade 2.
Q35194178	Progress in prophylactic and therapeutic vaccines for human papillomavirus infection
Q35552023	Progression of naive intraepithelial neoplasia genome to aggressive squamous cell carcinoma genome of uterine cervix
Q35097588	Promoter hypermethylation of KLF4 inactivates its tumor suppressor function in cervical carcinogenesis
Q34695790	Promoter hypermethylation-mediated inactivation of multiple Slit-Robo pathway genes in cervical cancer progression
Q80279628	Prophylactic DNA immunization against multiple papillomavirus types
Q24545449	Prophylactic human papillomavirus vaccines
Q51553092	Prospective evaluation of longitudinal changes in human papillomavirus genotype and phylogenetic clade associated with cervical disease progression.
Q38118374	Prospective evaluation of the Amplicor HPV test for predicting progression of cervical intraepithelial neoplasia 2.
Q37154142	Prospects and prejudices of human papillomavirus vaccines in India
Q36337922	Prospects of RNA interference therapy for cancer
Q21131365	Protective vaccination against papillomavirus-induced skin tumors under immunocompetent and immunosuppressive conditions: a preclinical study using a natural outbred animal model
Q33505686	Protein expression profile using two-dimensional gel analysis in squamous cervical cancer patients
Q24792502	Protein p16 as a marker of dysplastic and neoplastic alterations in cervical epithelial cells
Q59591350	Proteomic analysis reveals the actin cytoskeleton as cellular target for the human papillomavirus type 8
Q33415671	Proteomics analysis of protein expression and specific protein oxidation in human papillomavirus transformed keratinocytes upon UVB irradiation
Q38151763	Proteomics strategies to analyze HPV-transformed cells: relevance to cervical cancer.
Q36197642	Protocadherin PCDH10, involved in tumor progression, is a frequent and early target of promoter hypermethylation in cervical cancer.
Q80136333	Quadrivalent human papillomavirus recombinant vaccine
Q30866975	Quantifying mRNA and microRNA with qPCR in cervical carcinogenesis: a validation of reference genes to ensure accurate data
Q34161994	Quantifying the phylodynamic forces driving papillomavirus evolution
Q64939796	RANK-RANKL Signaling in Cancer of the Uterine Cervix: A Review.
Q35347785	RAP1 GTPase overexpression is associated with cervical intraepithelial neoplasia.
Q53843121	RETRACTED ARTICLE: Impact of Toll-Like Receptors 2/3/4/9, IL-1-α/β and TNF-α Polymorphisms in Cervical Cancer Susceptibility in Tunisia : Genetic polymorphisms implicated in the occurence of Cervical Cancer.
Q34634649	RKIP inhibition in cervical cancer is associated with higher tumor aggressive behavior and resistance to cisplatin therapy
Q37256248	RNA (E6 and E7) assays versus DNA (E6 and E7) assays for risk evaluation for women infected with human papillomavirus.
Q35834013	RNA Binding Proteins that Control Human Papillomavirus Gene Expression
Q37692493	RNA extraction method is crucial for human papillomavirus E6/E7 oncogenes detection
Q36028214	RNA polymerases I and III, growth control and cancer
Q37426219	RNA splicing factors regulated by HPV16 during cervical tumour progression.
Q35917676	RNAscope: a novel in situ RNA analysis platform for formalin-fixed, paraffin-embedded tissues
Q34796264	RPS19 and TYMS SNPs and Prevalent High Risk Human Papilloma Virus Infection in Nigerian Women
Q36376979	Rabbit Models for Studying Human Infectious Diseases
Q46751959	Rabbits immunised with recombinant BCG expressing the cottontail rabbit papillomavirus (CRPV) L2E7E2 genes induces regression of established papillomas
Q88657797	Racial differences in the prevalence of oncogenic oral human papillomavirus infection types in the United States adult population
Q50917885	Radiation-inducible protein RbAp48 contributes to radiosensitivity of cervical cancer cells.
Q39628028	Radiosensitization of Oropharyngeal Squamous Cell Carcinoma Cells by Human Papillomavirus 16 Oncoprotein E6∗I
Q49797507	Rational Design for Cervical Cancer Therapeutics: Cellular and Non-Cellular Based Strategies on the Horizon for Recurrent, Metastatic or Refractory Cervical Cancer.
Q35124750	Rationale and design of the iPap trial: a randomized controlled trial of home-based HPV self-sampling for improving participation in cervical screening by never- and under-screened women in Australia
Q44829262	Re: national prevalence of oral HPV infection and related risk factors in the U.S. adult population
Q98292027	Ready for Repair? Gene Editing Enters the Clinic for the Treatment of Human Disease
Q35195553	Recent Insights into the Control of Human Papillomavirus (HPV) Genome Stability, Loss, and Degradation
Q27010116	Recognition of human oncogenic viruses by host pattern-recognition receptors
Q42983370	Recombinant Kunjin virus replicon vaccines induce protective T-cell immunity against human papillomavirus 16 E7-expressing tumour
Q37709290	Recurrence of cervical cancer and its resistance to progestin therapy in a mouse model
Q33883497	Recurrent respiratory papillomatosis: a rare chronic disease, difficult to treat, with potential to lung cancer transformation: apropos of two cases and a brief literature review
Q34141721	Reduced expression of autophagy markers correlates with high-risk human papillomavirus infection in human cervical squamous cell carcinoma
Q24810952	Reduced expression of multiple gap junction proteins is a feature of cervical dysplasia
Q33828413	Regulation of MCP-1 chemokine transcription by p53
Q35856917	Regulation of Notch1 gene expression by p53 in epithelial cells
Q24304914	Regulation of cellular zinc balance as a potential mechanism of EVER-mediated protection against pathogenesis by cutaneous oncogenic human papillomaviruses
Q38087843	Regulation of human papillomavirus gene expression by splicing and polyadenylation
Q24293755	Regulation of immunity and oncogenesis by the IRF transcription factor family
Q37870408	Regulation of nucleocytoplasmic trafficking of viral proteins: an integral role in pathogenesis?
Q37053343	Regulation of telomerase and telomeres: human tumor viruses take control
Q26795741	Regulation of the Wnt/β-Catenin Signaling Pathway by Human Papillomavirus E6 and E7 Oncoproteins
Q37633137	Regulation of the life cycle of HPVs by differentiation and the DNA damage response
Q81166713	Relationship between the expression of telomerase and human papillomavirus infection in invasive uterine cervical carcinoma
Q35956619	Relevance of miR-21 in regulation of tumor suppressor gene PTEN in human cervical cancer cells
Q83890620	Reliability of sentinel node assay in vulvar cancer: the first Croatian validation trial
Q62022849	Reply: Breast cancer, human papilloma virus and sexual activities
Q64238726	Repression of Human Papillomavirus Oncogene Expression under Hypoxia Is Mediated by PI3K/mTORC2/AKT Signaling
Q37000743	Requirement for estrogen receptor alpha in a mouse model for human papillomavirus-associated cervical cancer
Q36522072	Requirement for stromal estrogen receptor alpha in cervical neoplasia
Q37537557	Requirement of estrogen receptor alpha DNA-binding domain for HPV oncogene-induced cervical carcinogenesis in mice
Q36579274	Retinoblastoma family proteins as key targets of the small DNA virus oncoproteins.
Q33795204	Retinoblastoma-independent antiproliferative activity of novel intracellular antibodies against the E7 oncoprotein in HPV 16-positive cells
Q53330192	Retinoic acid receptor beta silences human papillomavirus-18 oncogene expression by induction of de novo methylation and heterochromatinization of the viral control region.
Q33379617	Retracted: HPV16 E7-Dependent Transformation Activates NHE1 through a PKA-RhoA-Iinduced Inhibition of p38alpha
Q58106758	Retracted: The role of NF-κB and miRNA in oral cancer and cancer stem cells with or without HPV16 infection
Q39125214	Review on the role of the human Polyomavirus JC in the development of tumors.
Q37995108	Review: antibodies to cutaneous human papillomaviruses.
Q33745439	Revised terminology for cervical histopathology and its implications for management of high-grade squamous intraepithelial lesions of the cervix
Q37233963	Risk Factors for Oral Human Papillomavirus Infection in Healthy Individuals: A Systematic Review and Meta-Analysis
Q104111741	Risk factors for the development of high-grade dysplasia and carcinoma in patients with laryngeal squamous cell papillomas: Large retrospective cohort study
Q47549712	Risk of Human Papillomavirus Infection in Cancer-Prone Individuals: What We Know
Q38445391	Robust Differences in p16-Dependent Oropharyngeal Squamous Cell Carcinoma Distant Metastasis: Implications for Targeted Therapy
Q37111088	Robust production and passaging of infectious HPV in squamous epithelium of primary human keratinocytes
Q54600809	Role and predictive strength of transglutaminase type 2 expression in premalignant lesions of the cervix.
Q40743530	Role of Cdc6 in re-replication in cells expressing human papillomavirus E7 oncogene
Q35076696	Role of Cdk1 in the p53-independent abrogation of the postmitotic checkpoint by human papillomavirus E6
Q37002546	Role of WDHD1 in Human Papillomavirus-Mediated Oncogenesis Identified by Transcriptional Profiling of E7-Expressing Cells
Q36544412	Role of dual specificity tyrosine-phosphorylation-regulated kinase 1B (Dyrk1B) in S-phase entry of HPV E7 expressing cells from quiescence
Q37251638	Role of human papillomavirus and its detection in potentially malignant and malignant head and neck lesions: updated review
Q54765914	Role of human papillomavirus in penile cancer, penile intraepithelial squamous cell neoplasias and in genital warts.
Q35821717	Role of human papillomavirus in the development of head and neck squamous cell carcinomas
Q22305628	Role of human papillomaviruses in carcinogenesis
Q36060662	Role of infectious diseases in human carcinogenesis
Q40766665	Role of inflammasome genetics in susceptibility to HPV infection and cervical cancer development.
Q28588460	Role of mammalian Ecdysoneless in cell cycle regulation
Q34448400	Role of nuclear progesterone receptor isoforms in uterine pathophysiology
Q40199758	Role of quantitative p16INK4A mRNA assay and digital reading of p16INK4A immunostained sections in diagnosis of cervical intraepithelial neoplasia.
Q55613070	Role of the DNA Damage Response in Human Papillomavirus RNA Splicing and Polyadenylation.
Q33788843	Role of the E1--E4 protein in the differentiation-dependent life cycle of human papillomavirus type 31.
Q24309432	Role of the PDZ domain-binding motif of the oncoprotein E6 in the pathogenesis of human papillomavirus type 31
Q91983237	Roles for E1-independent replication and E6-mediated p53 degradation during low-risk and high-risk human papillomavirus genome maintenance
Q40804928	Roles of CDKN1A gene polymorphisms (rs1801270 and rs1059234) in the development of cervical neoplasia
Q42251888	Roles of the PDZ domain-binding motif of the human papillomavirus type 16 E6 on the immortalization and differentiation of primary human foreskin keratinocytes
Q27009016	Roles of the PI3K/Akt pathway in Epstein-Barr virus-induced cancers and therapeutic implications
Q39312249	Ruthenium oligonucleotides, targeting HPV16 E6 oncogene, inhibit the growth of cervical cancer cells under illumination by a mechanism involving p53.
Q35758021	S100A14, a mediator of epithelial-mesenchymal transition, regulates proliferation, migration and invasion of human cervical cancer cells.
Q54120638	S100A6 promotes the proliferation and migration of cervical cancer cells via the PI3K/Akt signaling pathway.
Q26798149	SAM68: Signal Transduction and RNA Metabolism in Human Cancer
Q36299791	SOX9, a potential tumor suppressor in cervical cancer, transactivates p21WAF1/CIP1 and suppresses cervical tumor growth
Q36431595	STAT-5 Regulates Transcription of the Topoisomerase IIβ-Binding Protein 1 (TopBP1) Gene To Activate the ATR Pathway and Promote Human Papillomavirus Replication.
Q34161997	SV40 and human tumours: myth, association or causality?
Q34454168	Screening and detection of human papillomavirus (HPV) high-risk strains HPV16 and HPV18 in saliva samples from subjects under 18 years old in Nevada: a pilot study
Q59806578	Screening of Cervical Cancer with Self-Collected Cervical Samples and Next-Generation Sequencing
Q90136486	Searching HPV genome for methylation sites involved in molecular progression to cervical precancer
Q39427565	Sensitivity of cervical carcinoma cells to vesicular stomatitis virus-induced oncolysis: potential role of human papilloma virus infection.
Q36610652	Sequential gene promoter methylation during HPV-induced cervical carcinogenesis
Q35773930	Seroepidemiology of Human Papillomavirus 16 (HPV16) L2 and Generation of L2-Specific Human Chimeric Monoclonal Antibodies
Q85238283	Serological markers for papillomavirus infection and skin tumour development in the rodent model Mastomys coucha
Q42488072	Seropositivity for human papillomavirus and incidence of subsequent squamous cell and basal cell carcinomas of the skin in patients with a previous nonmelanoma skin cancer.
Q53304618	Seroreactivity of 38 human papillomavirus types in epidermodysplasia verruciformis patients, relatives, and controls.
Q90569897	Serum and tissue miRNAs: potential biomarkers for the diagnosis of cervical cancer
Q92512534	Sexually transmitted infections and risk of epithelial ovarian cancer: results from the Nurses' Health Studies
Q37160973	Shift from apoptotic to necrotic cell death during human papillomavirus-induced transformation of keratinocytes
Q57284128	Short half-life of HPV16 E6 and E7 mRNAs sensitizes HPV16-positive tonsillar cancer cell line HN26 to DNA-damaging drugs
Q35642188	Short-term induction and long-term suppression of HPV16 oncogene silencing by RNA interference in cervical cancer cells
Q35589696	Significance of p53-binding protein 1 nuclear foci in uterine cervical lesions: endogenous DNA double strand breaks and genomic instability during carcinogenesis
Q27488437	Silencing Viral MicroRNA as a Novel Antiviral Therapy?
Q39176183	Silencing of human papillomavirus (HPV) E6/E7 oncogene expression affects both the contents and the amounts of extracellular microvesicles released from HPV-positive cancer cells
Q39476902	Silencing oncogene expression in cervical cancer stem-like cells inhibits their cell growth and self-renewal ability
Q40372322	Similarities and differences between the E5 oncoproteins of bovine papillomaviruses type 1 and type 4: cytoskeleton, motility and invasiveness in E5-transformed bovine and mouse cells
Q36165724	Single and multiple high-risk and low-risk Human Papillomavirus association with cervical lesions of 11,224 women in Jakarta
Q58547991	Single type infection of human papillomavirus as a cause for high-grade cervical intraepithelial neoplasia and invasive cancer in Japan
Q38253253	Site of infections associated with human papillomavirus
Q38317007	Skin human papillomavirus type 38 alters p53 functions by accumulation of deltaNp73.
Q39797498	Skin hyperproliferation and susceptibility to chemical carcinogenesis in transgenic mice expressing E6 and E7 of human papillomavirus type 38.
Q50900769	Skin microbiopsy for HPV DNA detection in cutaneous warts.
Q84630637	Small Molecule Inhibitors of the Human Papillomavirus E1-E2 Interaction
Q37855949	Smoking impairs human papillomavirus (HPV) type 16 and 18 capsids antibody response following natural HPV infection
Q34412697	Some novel insights on HPV16 related cervical cancer pathogenesis based on analyses of LCR methylation, viral load, E7 and E2/E4 expressions
Q28485410	Sonoporation delivery of monoclonal antibodies against human papillomavirus 16 E6 restores p53 expression in transformed cervical keratinocytes
Q33907700	Spontaneous and Vaccine-Induced Clearance of Mus Musculus Papillomavirus 1 Infection
Q34103672	Squamous cell carcinoma of the oropharynx in Australian males induced by human papillomavirus vaccine targets.
Q24299500	Stimulation of the Na(+)-coupled glucose transporter SGLT1 by B-RAF
Q37840092	Strategies for tumor-directed delivery of siRNA.
Q35081692	Stress management and psychoneuroimmunology in HIV infection.
Q58561183	Structural dynamics of the E6AP/UBE3A-E6-p53 enzyme-substrate complex
Q24292803	Structure of the human Papillomavirus E7 oncoprotein and its mechanism for inactivation of the retinoblastoma tumor suppressor
Q24294963	Structures of a human papillomavirus (HPV) E6 polypeptide bound to MAGUK proteins: mechanisms of targeting tumor suppressors by a high-risk HPV oncoprotein
Q34411810	Subcellular localization of the human papillomavirus 16 E7 oncoprotein in CaSki cells and its detection in cervical adenocarcinoma and adenocarcinoma in situ
Q91688100	Substitution of Human Papillomavirus Type 16 L2 Neutralizing Epitopes Into L1 Surface Loops: The Effect on Virus-Like Particle Assembly and Immunogenicity
Q40793270	Subtypes of HPV-Positive Head and Neck Cancers Are Associated with HPV Characteristics, Copy Number Alterations, PIK3CA Mutation, and Pathway Signatures
Q39330979	Successful therapeutic vaccination with integrase defective lentiviral vector expressing nononcogenic human papillomavirus E7 protein.
Q37528882	Suppression of HPV-16 late L1 5'-splice site SD3632 by binding of hnRNP D proteins and hnRNP A2/B1 to upstream AUAGUA RNA motifs
Q41924177	Suppression of MicroRNA 424 Levels by Human Papillomaviruses Is Necessary for Differentiation-Dependent Genome Amplification
Q35192650	Suppression of STAT-1 expression by human papillomaviruses is necessary for differentiation-dependent genome amplification and plasmid maintenance
Q58090950	Suppression of miR-22, a tumor suppressor in cervical cancer, by human papillomavirus 16 E6 via a p53/miR-22/HDAC6 pathway
Q91814172	Surfactant Protein A Impairs Genital HPV16 Pseudovirus Infection by Innate Immune Cell Activation in A Murine Model
Q64235949	Survey of cervical cancer and precancerous lesion prevention knowledge within community health service centers in Shanghai, China
Q38000885	Susceptibility to cervical cancer: an overview
Q97870313	Sustainable Tumor-Suppressive Effect of iPSC-Derived Rejuvenated T Cells Targeting Cervical Cancers
Q92335202	Synthesis and Evaluation of Anisomelic acid-like Compounds for the Treatment of HPV-Mediated Carcinomas
Q47193677	Systematic assessment of cervical cancer initiation and progression uncovers genetic panels for deep learning-based early diagnosis and proposes novel diagnostic and prognostic biomarkers
Q21144267	Systemic therapy for cervical cancer with potentially regulatable oncolytic adenoviruses
Q34475726	T cell-tumor interaction directs the development of immunotherapies in head and neck cancer
Q34150378	T-cell response to human papillomavirus type 58 L1, E6, And E7 peptides in women with cleared infection, cervical intraepithelial neoplasia, or invasive cancer
Q35242522	TALEN-mediated targeting of HPV oncogenes ameliorates HPV-related cervical malignancy
Q40317235	TAp63alpha indirectly regulates a cutaneous HPV promoter through complex formation with Jun family members
Q40022812	TGF-beta1 and IL-4 downregulate human papillomavirus-16 oncogene expression but have differential effects on the malignant phenotype of cervical carcinoma cells.
Q47103541	TIP60 represses telomerase expression by inhibiting Sp1 binding to the TERT promoter.
Q84148682	TNF-α and IL-10 promoter polymorphisms, HPV infection, and cervical cancer risk
Q34239911	TP53 and PIK3CA gene mutations in adenocarcinoma, squamous cell carcinoma and high-grade intraepithelial neoplasia of the cervix
Q40588855	TSLC1 gene silencing in cervical cancer cell lines and cervical neoplasia
Q61444373	TaME-seq: An efficient sequencing approach for characterisation of HPV genomic variability and chromosomal integration
Q50052586	Targeted immunotherapy of high-grade cervical intra-epithelial neoplasia: Expectations from clinical trials
Q37494787	Targeting immune response with therapeutic vaccines in premalignant lesions and cervical cancer: hope or reality from clinical studies
Q38870528	Targeting the Two Oncogenic Functional Sites of the HPV E6 Oncoprotein with a High-Affinity Bivalent Ligand
Q38620705	Temporal bone carcinoma: a first glance beyond the conventional clinical and pathological prognostic factors.
Q94571426	Tetraspanin CD9 affects HPV16 infection by modulating ADAM17 activity and the ERK signalling pathway
Q45715256	The 46359CT polymorphism of DNMT3B is associated with the risk of cervical cancer
Q64110104	The Accuracy of Anal Swab–Based Tests to Detect High-Grade Anal Intraepithelial Neoplasia in HIV-Infected Patients: A Systematic Review and Meta-analysis
Q52594218	The Association of Dietary Patterns with High-Risk Human Papillomavirus Infection and Cervical Cancer: A Cross-Sectional Study in Italy.
Q27490470	The Canine Papillomavirus E5 Protein Signals from the Endoplasmic Reticulum
Q30989066	The Canine Papillomavirus and Gamma HPV E7 Proteins Use an Alternative Domain to Bind and Destabilize the Retinoblastoma Protein
Q41902984	The Correlation between Chronic Periodontitis and Oral Cancer
Q59351344	The Deubiquitinase USP46 Is Essential for Proliferation and Tumor Growth of HPV-Transformed Cancers
Q90458447	The Diagnostic Utility of p16 Immunostaining in Differentiating Cancer and HSIL from LSIL and Benign in Cervical Cells
Q35826243	The E1 protein of human papillomavirus type 16 is dispensable for maintenance replication of the viral genome
Q35903743	The E6 oncoprotein from HPV16 enhances the canonical Wnt/β-catenin pathway in skin epidermis in vivo
Q28544832	The E6AP binding pocket of the HPV16 E6 oncoprotein provides a docking site for a small inhibitory peptide unrelated to E6AP, indicating druggability of E6
Q24545831	The E7 oncoprotein is translated from spliced E6*I transcripts in high-risk human papillomavirus type 16- or type 18-positive cervical cancer cell lines via translation reinitiation
Q34249834	The E7 proteins of low- and high-risk human papillomaviruses share the ability to target the pRB family member p130 for degradation
Q37232535	The EVER proteins as a natural barrier against papillomaviruses: a new insight into the pathogenesis of human papillomavirus infections
Q91716484	The Effects of the Dietary and Nutrient Intake on Gynecologic Cancers
Q36867985	The Fanconi anemia pathway: repairing the link between DNA damage and squamous cell carcinoma.
Q40625957	The Fidelity of HPV16 E1/E2-mediated DNA Replication
Q41827384	The HPV-16 E7 oncoprotein induces centriole multiplication through deregulation of Polo-like kinase 4 expression
Q35895297	The Human Papillomavirus E6 PDZ Binding Motif: From Life Cycle to Malignancy
Q34964035	The ING4 Binding with p53 and Induced p53 Acetylation were Attenuated by Human Papillomavirus 16 E6.
Q41888239	The IRF family of transcription factors: Inception, impact and implications in oncogenesis
Q54215275	The Impact of Human Papilloma Viruses, Matrix Metallo-Proteinases and HIV Protease Inhibitors on the Onset and Progression of Uterine Cervix Epithelial Tumors: A Review of Preclinical and Clinical Studies.
Q28485982	The JAK-STAT transcriptional regulator, STAT-5, activates the ATM DNA damage pathway to induce HPV 31 genome amplification upon epithelial differentiation
Q36115993	The Magnitude of the Association between Human Papillomavirus and Oral Lichen Planus: A Meta-Analysis
Q52563269	The Novel Roles of Connexin Channels and Tunneling Nanotubes in Cancer Pathogenesis.
Q47105021	The PDZ-Binding Motif of HPV16-E6 Oncoprotein Modulates the Keratinization and Stemness Transcriptional Profile In Vivo
Q26851181	The Possible Effects on Socio-Economic Inequalities of Introducing HPV Testing as Primary Test in Cervical Cancer Screening Programs
Q45355529	The PxDLLCxE sequence in conserved region 2 of human papilloma virus 18 protein E7 is required for E7 binding to centromere protein C.
Q37462102	The RNA stability regulator HuR regulates L1 protein expression in vivo in differentiating cervical epithelial cells
Q26739983	The Role of Natural Polyphenols in the Prevention and Treatment of Cervical Cancer-An Overview
Q35185640	The Role of Proteomics in the Diagnosis and Treatment of Women's Cancers: Current Trends in Technology and Future Opportunities
Q90145439	The Roles of HK2 on Tumorigenesis of Cervical Cancer
Q60960084	The Use of HPV16-E5, EGFR, and pEGFR as Prognostic Biomarkers for Oropharyngeal Cancer Patients
Q40270627	The VPS4 component of the ESCRT machinery plays an essential role in HPV infectious entry and capsid disassembly
Q28256824	The acetyltransferase Tip60 is a critical regulator of the differentiation-dependent amplification of human papillomaviruses
Q38113517	The adolescent and young adult with cancer: state of the art--epithelial cancer
Q33911922	The anti-aging gene KLOTHO is a novel target for epigenetic silencing in human cervical carcinoma
Q34906058	The aqueous extract of Ficus religiosa induces cell cycle arrest in human cervical cancer cell lines SiHa (HPV-16 Positive) and apoptosis in HeLa (HPV-18 positive).
Q99709734	The association between HPV gene expression, inflammatory agents and cellular genes involved in EMT in lung cancer tissue
Q37197245	The association between methylated CDKN2A and cervical carcinogenesis, and its diagnostic value in cervical cancer: a meta-analysis
Q37617163	The biological properties of E6 and E7 oncoproteins from human papillomaviruses.
Q38205174	The clinical impact of using p16(INK4a) immunochemistry in cervical histopathology and cytology: an update of recent developments
Q38168923	The current position and the future perspectives of cervical cancer screening
Q39033576	The current state of therapeutic and T cell-based vaccines against human papillomaviruses
Q53176478	The direct and indirect association of cervical microbiota with the risk of cervical intraepithelial neoplasia.
Q37142007	The dynamic DNA methylomes of double-stranded DNA viruses associated with human cancer
Q82845796	The early noncoding region of human papillomavirus type 16 is regulated by cytoplasmic polyadenylation factors
Q44553066	The epithelial-mesenchymal transition induced by keratinocyte growth conditions is overcome by E6 and E7 from HPV16, but not HPV8 and HPV38: characterization of global transcription profiles.
Q34321558	The etiologic role of human papillomavirus in penile cancers: a study in Vietnam
Q26741362	The etiologic spectrum of head and neck squamous cell carcinoma in young patients
Q64065288	The free energy landscape of the oncogene protein E7 of human papillomavirus type 16 reveals a complex interplay between ordered and disordered regions
Q24521626	The global transcriptional effects of the human papillomavirus E6 protein in cervical carcinoma cell lines are mediated by the E6AP ubiquitin ligase
Q36679858	The hallmarks of premalignant conditions: a molecular basis for cancer prevention
Q42277084	The heterogeneous structural behavior of E7 from HPV16 revealed by NMR spectroscopy
Q34646782	The high-risk HPV16 E7 oncoprotein mediates interaction between the transcriptional coactivator CBP and the retinoblastoma protein pRb.
Q24610004	The history of tumor virology
Q91887783	The human papillomavirus 16 E5 gene potentiates MmuPV1-Dependent pathogenesis
Q37325199	The human papillomavirus E7 oncoprotein
Q30410482	The human papillomavirus E7 proteins associate with p190RhoGAP and alter its function
Q40627005	The human papillomavirus HPV2a E5 protein localizes to the Golgi apparatus and modulates signal transduction
Q40075752	The human papillomavirus type 16 E7 oncoprotein activates the Fanconi anemia (FA) pathway and causes accelerated chromosomal instability in FA cells
Q39440454	The human papillomavirus type 16 E7 oncoprotein targets Myc-interacting zinc-finger protein-1.
Q33638499	The human papillomavirus type 58 E7 oncoprotein modulates cell cycle regulatory proteins and abrogates cell cycle checkpoints
Q24294390	The human papillomavirus-16 E7 oncoprotein exerts antiapoptotic effects via its physical interaction with the actin-binding protein gelsolin
Q41209527	The human papillomavirus18 E7 protein inhibits CENP-C binding to α-satellite DNA.
Q36949687	The immunopathobiology of syphilis: the manifestations and course of syphilis are determined by the level of delayed-type hypersensitivity
Q41468022	The impact of human papillomavirus infection on the survival and treatment response of patients with esophageal cancers
Q35245080	The interferon-related developmental regulator 1 is used by human papillomavirus to suppress NFκB activation.
Q47098228	The interplay of UV and cutaneous papillomavirus infection in skin cancer development
Q30248605	The intestinal microbiome and surgical disease.
Q30010159	The invasive capacity of HPV transformed cells requires the hDlg-dependent enhancement of SGEF/RhoG activity
Q36541450	The invisible enemy - how human papillomaviruses avoid recognition and clearance by the host immune system
Q37250972	The landscape of viral expression and host gene fusion and adaptation in human cancer
Q42760691	The mechanism and implications of hScrib regulation of ERK.
Q37821229	The molecular biology of head and neck cancer
Q38875247	The molecular mechanism of human papillomavirus-induced carcinogenesis in head and neck squamous cell carcinoma
Q36691070	The natural history of cervical HPV infection: unresolved issues
Q34994783	The overexpression of scaffolding protein NEDD9 promotes migration and invasion in cervical cancer via tyrosine phosphorylated FAK and SRC.
Q33843385	The paediatric story of human papillomavirus (Review).
Q37729872	The papillomavirus E7 oncoprotein is ubiquitinated by UbcH7 and Cullin 1- and Skp2-containing E3 ligase
Q37198662	The papillomavirus E7 proteins
Q92256596	The potential of RNA as a target for national screening of pre-cancer
Q38424974	The potential of plants for the production and delivery of human papillomavirus vaccines
Q58738110	The precision prevention and therapy of HPV-related cervical cancer: new concepts and clinical implications
Q30809203	The presence of human papillomavirus 16 in neural structures and vascular endothelial cells.
Q79653324	The presence of inhibitory RNA elements in the late 3'-untranslated region is a conserved property of human papillomaviruses
Q92932816	The prostaglandin receptor EP2 determines prognosis in EP3-negative and galectin-3-high cervical cancer cases
Q40912702	The protective role of the -1306C>T functional polymorphism in matrix metalloproteinase-2 gene is associated with cervical cancer: implication of human papillomavirus infection
Q38432998	The relationship between c-FLIP expression and human papillomavirus E2 gene disruption in cervical carcinogenesis
Q40635050	The relationship between connexins, gap junctions, tissue architecture and tumour invasion, as studied in a novel in vitro model of HPV-16-associated cervical cancer progression
Q51582518	The relationship between cytokines and HPV-16, HPV-16 E6, E7, and high-risk HPV viral load in the uterine cervix.
Q42204716	The rise and fall of infectious diseases: Australian perspectives, 1914-2014.
Q37256444	The role of Notch signaling in human cervical cancer: implications for solid tumors
Q35078768	The role of TP53 in Cervical carcinogenesis.
Q54393366	The role of high-risk human papillomavirus infection in oral and oropharyngeal squamous cell carcinoma in non-smoking and non-drinking patients: a clinicopathological and molecular study of 46 cases.
Q38069126	The role of human papillomavirus in nongenital cancers
Q38067674	The role of human papillomavirus in oral squamous cell carcinoma: myth and reality.
Q41918104	The role of human papillomavirus in p16 positive oral cancers
Q37841300	The role of human papillomavirus infection in breast cancer
Q34983628	The role of human papillomavirus oncoproteins E6 and E7 in apoptosis
Q54673771	The role of human telomerase catalytic subunit mRNA expression in cervical dysplasias.
Q35838573	The role of the PI3K/Akt/mTOR signalling pathway in human cancers induced by infection with human papillomaviruses
Q40211890	The role of the ubiquitin ligase E6-AP in human papillomavirus E6-mediated degradation of PDZ domain-containing proteins
Q37460979	The role of vimentin as a methylation biomarker for early diagnosis of cervical cancer
Q82324394	The study of the combination detection of HPV-DNA and p16INK4a in cervical lesions
Q39792491	The transcription factors TBX2 and TBX3 interact with human papillomavirus 16 (HPV16) L2 and repress the long control region of HPVs
Q34333425	The tumor suppressor protein p16(INK4a) and the human papillomavirus oncoprotein-58 E7 are naturally occurring lysine-less proteins that are degraded by the ubiquitin system. Direct evidence for ubiquitination at the N-terminal residue
Q46764804	The tyrphostin B42 inhibits cell proliferation and HER-2 autophosphorylation in cervical carcinoma cell lines.
Q37710125	The use of rapid and cost-effective blood-based biomarkers in combination with tumour TNM stage for individual head and neck cancer patient treatment selection
Q38002927	The use of sinecatechins (polyphenon E) ointment for treatment of external genital warts
Q33936427	Therapeutic HPV DNA vaccines
Q84504653	Therapeutic HPV DNA vaccines
Q36540533	Therapeutic Human Papillomavirus (HPV) Vaccines: A Novel Approach
Q35826752	Therapeutic Vaccine Strategies against Human Papillomavirus
Q36726461	Therapeutic human papillomavirus DNA vaccination strategies to control cervical cancer
Q56937332	Therapeutic human papillomavirus vaccines: current clinical trials and future directions
Q36572609	Therapeutic immunisation of rabbits with cottontail rabbit papillomavirus (CRPV) virus-like particles (VLP) induces regression of established papillomas
Q47255618	Therapeutic vaccines for high-risk HPV-associated diseases.
Q36285957	Thiol-reactive reagents inhibits intracellular trafficking of human papillomavirus type 16 pseudovirions by binding to cysteine residues of major capsid protein L1.
Q45870866	Tissue factor knockdown in porcine islets: an effective approach to suppressing the instant blood-mediated inflammatory reaction
Q60951117	Tobacco Exposure Enhances Human Papillomavirus 16 Oncogene Expression via EGFR/PI3K/Akt/c-Jun Signaling Pathway in Cervical Cancer Cells
Q34260248	Tobacco exposure results in increased E6 and E7 oncogene expression, DNA damage and mutation rates in cells maintaining episomal human papillomavirus 16 genomes
Q40751007	Toll-like receptor 2 gene polymorphisms in Korean women with human papillomavirus-related cervical neoplasia
Q42286778	Toll-like receptor 9 (TLR9) gene polymorphisms associated with increased susceptibility of human papillomavirus-16 infection in patients with cervical cancer
Q39806563	Topography of bovine papillomavirus E2 protein on the viral genome during the cell cycle.
Q90989905	Topoisomerase IIβ-binding protein 1 activates expression of E2F1 and p73 in HPV-positive cells for genome amplification upon epithelial differentiation
Q35660073	Towards a "Sample-In, Answer-Out" Point-of-Care Platform for Nucleic Acid Extraction and Amplification: Using an HPV E6/E7 mRNA Model System
Q48035563	Transcriptional activation of H- and N-ras oncogenes in human cervical cancer
Q39447712	Transcriptional gene silencing of HPV16 E6/E7 induces growth inhibition via apoptosis in vitro and in vivo
Q37110658	Transcriptional regulation of E-cadherin and oncoprotein E7 by valproic acid in HPV positive cell lines
Q35203515	Transcriptionally active regions are the preferred targets for chromosomal HPV integration in cervical carcinogenesis
Q36064347	Transcriptomic analyses of genes differentially expressed by high-risk and low-risk human papilloma virus E6 oncoproteins
Q45359462	Transient expression of Human papillomavirus type 16 L2 epitope fused to N- and C-terminus of coat protein of Potato virus X in plants
Q36793117	Translational mini-review series on vaccines: Monitoring of human papillomavirus vaccination
Q26777676	Translational progress on tumor biomarkers
Q38036688	Treatment failure in patients with HPV 16-induced vulvar intraepithelial neoplasia: understanding different clinical responses to immunotherapy.
Q36874310	Treatment with proteasome inhibitor bortezomib enhances antigen-specific CD8+ T-cell-mediated antitumor immunity induced by DNA vaccination
Q40003861	Trends and predictors of HPV vaccination among U.S. College women and men.
Q35108590	Triage of HR-HPV positive women with minor cytological abnormalities: a comparison of mRNA testing, HPV DNA testing, and repeat cytology using a 4-year follow-up of a population-based study
Q37294687	Triage of women with equivocal or low-grade cervical cytology results: a meta-analysis of the HPV test positivity rate
Q34019808	Triage of women with low-grade cervical lesions--HPV mRNA testing versus repeat cytology
Q33698073	Triage of women with minor cervical lesions: data suggesting a "test and treat" approach for HPV E6/E7 mRNA testing
Q21710719	Tripolar mitosis in human cells and embryos: Occurrence, pathophysiology and medical implications
Q44061280	Tumor-specific and gender-specific pre-vaccination distribution of human papillomavirus types 6 and 11 in anogenital warts and laryngeal papillomas: a study on 574 tissue specimens
Q40046664	Tumour virus epidemiology
Q33831016	Tumourigenesis driven by the human papillomavirus type 16 Asian-American e6 variant in a three-dimensional keratinocyte model
Q21143868	Two highly conserved cysteine residues in HPV16 L2 form an intramolecular disulfide bond and are critical for infectivity in human keratinocytes
Q35862870	Two less common human microRNAs miR-875 and miR-3144 target a conserved site of E6 oncogene in most high-risk human papillomavirus subtypes
Q33220554	Two-dimensional gel analysis of protein expression profile in squamous cervical cancer patients
Q34477097	Type-specific detection of 30 oncogenic human papillomaviruses by genotyping both E6 and L1 genes
Q36525401	Type-specific interaction between human papillomavirus type 58 E2 protein and E7 protein inhibits E7-mediated oncogenicity
Q36817074	US assessment of HPV types in cancers: implications for current and 9-valent HPV vaccines
Q40097000	UVB irradiation down-regulates HPV-16 RNA expression: implications for malignant progression of transformed cells.
Q34503492	Ubiquitin becomes ubiquitous in cancer: emerging roles of ubiquitin ligases and deubiquitinases in tumorigenesis and as therapeutic targets
Q64103520	Unusual prevalence of high-risk genotypes of human papillomavirus in a group of women with neoplastic lesions and cervical cancer from Central Mexico
Q44092048	Upregulation of nuclear factor-kappaB (NF-kappaB) is related to the grade of cervical intraepithelial neoplasia, but is not an independent predictor of high-risk human papillomavirus or disease outcome in cervical cancer
Q34978068	Using HLA-A2.1 Transgenic Rabbit Model to Screen and Characterize New HLA-A2.1 Restricted Epitope DNA Vaccines.
Q33491567	Using LongSAGE to Detect Biomarkers of Cervical Cancer Potentially Amenable to Optical Contrast Agent Labelling
Q90189471	Utility of Human Papillomavirus Testing for Cervical Cancer Screening in Korea
Q90115301	Utility of human papillomavirus L1 capsid protein and HPV test as prognostic markers for cervical intraepithelial neoplasia 2+ in women with persistent ASCUS /LSIL cervical cytology
Q34151939	Utilization of Boron Compounds for the Modification of Suberoyl Anilide Hydroxamic Acid as Inhibitor of Histone Deacetylase Class II Homo sapiens.
Q55194696	VEGF +936 C/T Genetic Polymorphism in Patients with Cervical Dysplasia.
Q37773831	Vaccination against human papilloma virus (HPV): epidemiological evidence of HPV in non-genital cancers.
Q40802250	Vaccination during myeloid cell depletion by cancer chemotherapy fosters robust T cell responses
Q34078674	Vaccination with HPV16 L2E6E7 fusion protein in GPI-0100 adjuvant elicits protective humoral and cell-mediated immunity.
Q36581107	Validation of Serological Antibody Profiles Against Human Papillomavirus Type 16 Antigens as Markers for Early Detection of Cervical Cancer.
Q92617082	Variant sublineages of human papillomavirus type 16 predispose women to persistent infection characterized by a sequence analysis of the E6, L1, and LCR regions
Q33894872	View and review on viral oncology research
Q47104746	Viral E6/E7 oncogene and cellular hexokinase 2 expression in HPV-positive cancer cell lines.
Q47571734	Viral Oncology: Molecular Biology and Pathogenesis
Q30702069	Viral expression associated with gastrointestinal adenocarcinomas in TCGA high-throughput sequencing data
Q34394771	Viral oncogenes, noncoding RNAs, and RNA splicing in human tumor viruses
Q41932233	Viral-Cellular DNA Junctions as Molecular Markers for Assessing Intra-Tumor Heterogeneity in Cervical Cancer and for the Detection of Circulating Tumor DNA.
Q24653900	Viruses associated with human cancer
Q98943925	WDHD1 facilitates G1 checkpoint abrogation in HPV E7 expressing cells by modulating GCN5
Q64053261	Whole genome sequencing reveals complexity in both HPV sequences present and HPV integrations in HPV-positive oropharyngeal squamous cell carcinomas
Q64941024	Whole-Genome Analysis of Human Papillomavirus Type 16 Prevalent in Japanese Women with or without Cervical Lesions.
Q40091466	Whole-genome analysis of human papillomavirus genotypes 52 and 58 isolated from Japanese women with cervical intraepithelial neoplasia and invasive cervical cancer.
Q51148925	Within-Host Variations of Human Papillomavirus Reveal APOBEC-Signature Mutagenesis in the Viral Genome.
Q38737157	Wnt-11 overexpression promoting the invasion of cervical cancer cells
Q39108721	Wogonin induces apoptosis by suppressing E6 and E7 expressions and activating intrinsic signaling pathways in HPV-16 cervical cancer cells
Q34642665	Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis
Q36261743	ZEB1 promotes the progression and metastasis of cervical squamous cell carcinoma via the promotion of epithelial-mesenchymal transition
Q52919235	[Detection of papillomavirus DNA in the prostate: a virus with underestimated clinical relevance?].
Q53184504	[Diagnosis and grading of cervical intraepithelial neoplasias].
Q89422224	[Epidemiology, prevention and early detection of cervical cancer]
Q54573284	[HPV-associated head and neck cancer. The basics of molecular and translational research].
Q82333479	[Human papillomaviruses in the pathogenesis of intraepithelial neoplasia (AIN) and carcinoma of the anus]
Q53218333	[Malignancy potential of precursor lesions: determination using molecular markers].
Q53357494	[Molecular pathogenesis of cervical cancer and its first steps].
Q80465505	[Papillomavirus diseases]
Q53281884	[Precancerous lesions of the uterine cervix: morphology and molecular pathology].
Q52903256	[Prophylactic and therapeutic vaccines against human papilloma virus].
Q79939143	[Prophylactic vaccination against human papillomavirus]
Q53370913	[Viral carcinogenesis of head and neck tumors].
Q40015788	hAda3 degradation by papillomavirus type 16 E6 correlates with abrogation of the p14ARF-p53 pathway and efficient immortalization of human mammary epithelial cells
Q33730462	hrHPV E5 oncoprotein: immune evasion and related immunotherapies.
Q42192987	mRNA biomarker detection in liquid-based cytology: a new approach in the prevention of cervical cancer
Q40570781	mTOR inhibition prevents rapid-onset of carcinogen-induced malignancies in a novel inducible HPV-16 E6/E7 mouse model.
Q37699192	miR-1 inhibits progression of high-risk papillomavirus-associated human cervical cancer by targeting G6PD.
Q39026464	miR-135a leads to cervical cancer cell transformation through regulation of β-catenin via a SIAH1-dependent ubiquitin proteosomal pathway.
Q34442631	miR-205 expression promotes cell proliferation and migration of human cervical cancer cells
Q34931601	miR-21: a small multi-faceted RNA.
Q37057240	miR-2861 acts as a tumor suppressor via targeting EGFR/AKT2/CCND1 pathway in cervical cancer induced by human papillomavirus virus 16 E6
Q37624605	miR-3156-3p is downregulated in HPV-positive cervical cancer and performs as a tumor-suppressive miRNA.
Q37270641	p16 as a diagnostic marker of cervical neoplasia: a tissue microarray study of 796 archival specimens
Q42203359	p16(INK4a) overexpression is not linked to oncogenic human papillomaviruses in patients with high-grade urothelial cancer cells
Q82639364	p16INK4A overexpression and HPV infection in uterine cervix adenocarcinoma
Q53564942	p16INK4A-silencing augments DNA damage-induced apoptosis in cervical cancer cells.
Q52552103	p16INK4AImmunohistochemical Overexpression in Premalignant and Malignant Oral Lesions Infected with Human Papillomavirus
Q34991379	p38MAPK and MK2 pathways are important for the differentiation-dependent human papillomavirus life cycle
Q41924608	p53 controls expression of the DNA deaminase APOBEC3B to limit its potential mutagenic activity in cancer cells
Q40185793	p53 regulates ERK activation in carboplatin induced apoptosis in cervical carcinoma: a novel target of p53 in apoptosis.
Q35192806	p63 is necessary for the activation of human papillomavirus late viral functions upon epithelial differentiation
Q34227843	siRNA targeting of the viral E6 oncogene efficiently kills human papillomavirus-positive cancer cells
Q35585348	β-HPV 5 and 8 E6 disrupt homology dependent double strand break repair by attenuating BRCA1 and BRCA2 expression and foci formation

scholarly article	Q13442814
review article	Q7318358

P6179	Dimensions Publication ID	1030753299
P356	DOI	10.1038/NRC798
P3181	OpenCitations bibliographic resource ID	153628
P698	PubMed publication ID	12044010
P5875	ResearchGate publication ID	11329273

P50	author	Harald zur Hausen	Q75847
P2860	cites work	A new type of papillomavirus DNA, its presence in genital cancer biopsies and in cell lines derived from cervical cancer	Q24555647
		A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions	Q24599668
		Regulation of the Src family tyrosine kinase Blk through E6AP-mediated ubiquitination	Q24656742
		Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis	Q28143403
		Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group	Q28241816
		The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product	Q29618372
		Safety and immunogenicity trial in adult volunteers of a human papillomavirus 16 L1 virus-like particle vaccine	Q31961522
		Inhibition of Bak-induced apoptosis by HPV-18 E6.	Q33292381
		The human papillomavirus E7 oncoprotein can uncouple cellular differentiation and proliferation in human keratinocytes by abrogating p21Cip1-mediated inhibition of cdk2.	Q33292423
		Systemic immunization with papillomavirus L1 protein completely prevents the development of viral mucosal papillomas	Q33707499
		Progress in adeno-associated virus type 2 vector production: promises and prospects for clinical use.	Q33763911
		Chimeric virus-like particles of the human papillomavirus type 16 (HPV 16) as a prophylactic and therapeutic vaccine	Q33780088
		Nasal immunization of mice with human papillomavirus type 16 virus-like particles elicits neutralizing antibodies in mucosal secretions	Q33784891
		Transcriptional activation of the telomerase hTERT gene by human papillomavirus type 16 E6 oncoprotein	Q33840150
		Retinoic acid-mediated repression of human papillomavirus 18 transcription and different ligand regulation of the retinoic acid receptor beta gene in non-tumorigenic and tumorigenic HeLa hybrid cells	Q33937895
		Nasal and vaginal vaccinations have differential effects on antibody responses in vaginal and cervical secretions in humans	Q34009698
		Clinical studies of human papilloma vaccines in pre-invasive and invasive cancer.	Q34189203
		Human papillomavirus-associated head and neck squamous cell carcinoma: mounting evidence for an etiologic role for human papillomavirus in a subset of head and neck cancers	Q34221597
		Human papilloma viruses (HPV): Characterization of four different isolates	Q34263866
		HPV testing in cervical screening	Q34288068
		Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group	Q34313864
		Disturbance of tumor necrosis factor alpha-mediated beta interferon signaling in cervical carcinoma cells	Q34326864
		Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia	Q34469288
		Expression of vaccinia recombinant HPV 16 L1 and L2 ORF proteins in epithelial cells is sufficient for assembly of HPV virion-like particles.	Q34505761
		Human papilloma virus DNA: physical mapping and genetic heterogeneity	Q34678465
		Inhibition of CDK activity and PCNA-dependent DNA replication by p21 is blocked by interaction with the HPV-16 E7 oncoprotein	Q34742793
		Induction of apoptosis in human papillomaviruspositive cancer cells by peptide aptamers targeting the viral E6 oncoprotein	Q35797390
		Immunization with viruslike particles from cottontail rabbit papillomavirus (CRPV) can protect against experimental CRPV infection.	Q35840539
		Chimeric papillomavirus virus-like particles elicit antitumor immunity against the E7 oncoprotein in an HPV16 tumor model	Q35891225
		???	Q57270107
		The ubiquitin-proteasome pathway in cancer	Q36295120
		Conserved polynucleotide sequences among the genomes of papillomaviruses	Q36503582
		Reversible repression of papillomavirus oncogene expression in cervical carcinoma cells: consequences for the phenotype and E6-p53 and E7-pRB interactions	Q36633110
		Characterization of a New Type of Human Papillomavirus That Causes Skin Warts	Q37507009
		Human papilloma virus DNAs immortalize normal human mammary epithelial cells and reduce their growth factor requirements	Q37669730
		E5 protein of human papillomavirus type 16 protects human foreskin keratinocytes from UV B-irradiation-induced apoptosis	Q39681753
		Antioxidant-induced changes of the AP-1 transcription complex are paralleled by a selective suppression of human papillomavirus transcription.	Q39877687
		Role of Bak in UV-induced apoptosis in skin cancer and abrogation by HPV E6 proteins	Q40445624
		Induction of apoptosis by cidofovir in human papillomavirus (HPV)-positive cells.	Q40770099
		Retinoic acid and interferon combination studies in human cancer	Q40790072
		The HPV16 E5 Protein: Expression, Detection, and Stable Complex Formation with Transmembrane Proteins in COS Cells	Q41316944
		Therapeutic approaches to papillomavirus infections	Q41428929
		Long-term genome stability and minimal genotypic and phenotypic alterations in HPV16 E7-, but not E6-, immortalized human uroepithelial cells	Q41442148
		Regulation of early gene expression of human papillomavirus type 16 by inflammatory cytokines	Q41476955
		Increased tumorigenicity of human keratinocytes harboring human papillomavirus type 16 is associated with resistance to endogenous tumor necrosis factor-alpha-mediated growth limitation	Q41487518
		Structure and transcription of human papillomavirus sequences in cervical carcinoma cells	Q41914039
		Human papillomavirus infections in women with and without abnormal cervical cytology	Q42000858
		Inhibitors of histone deacetylase arrest cell cycle and induce apoptosis in cervical carcinoma cells circumventing human papillomavirus oncogene expression	Q42657689
		Interferon-beta and -gamma, but not tumor necrosis factor-alpha, demonstrate immunoregulatory effects on carcinoma cell lines infected with human papillomavirus	Q43450149
		Spontaneous regression of CIN and delayed-type hypersensitivity to HPV-16 oncoprotein E7.	Q43656092
		Association of human papillomavirus types 16 and 18 E6 proteins with p53.	Q43701619
		HPV6b virus like particles are potent immunogens without adjuvant in man.	Q44456772
		Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells.	Q44816904
		A recombinant vaccinia virus encoding human papillomavirus types 16 and 18, E6 and E7 proteins as immunotherapy for cervical cancer.	Q45769906
		Attempts to detect virus-secific DNA in human tumors. I. Nucleic acid hybridizations with complementary RNA of human wart virus	Q45818265
		Selective down-regulation of human papillomavirus transcription by 2-deoxyglucose	Q48017824
		Conversion of HPV 18 positive non-tumorigenic HeLa-fibroblast hybrids to invasive growth involves loss of TNF-alpha mediated repression of viral transcription and modification of the AP-1 transcription complex.	Q53422900
		The causal link between human papillomavirus and invasive cervical cancer: a population-based case-control study in Colombia and Spain	Q57252132
		Persistent Genital Human Papillomavirus Infection as a Risk Factor for Persistent Cervical Dysplasia	Q60197523
		Inhibition of tumorigenicity of cervical cancer cells in nude mice by HPV e6‐e7 anti‐sense RNA	Q67490608
		Evaluation of topically applied trans-retinoic acid in the treatment of cervical intraepithelial lesions	Q70251015
		New Epidemiology of Human Papillomavirus Infection and Cervical Neoplasia	Q72019230
		Cellular immunodeficiency enhances the progression of human papillomavirus-associated cervical lesions	Q72680272
		Partial characterization of viral DNA from human genital warts (condylomata acuminata)	Q72849622
		Overexpression of p16(INK4A) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri	Q73721770
		Estimates of the world-wide prevalence of cancer for 25 sites in the adult population	Q77440979
P433	issue	5
P407	language of work or name	English	Q1860
P921	main subject	Papillomavirus	Q1137717
P304	page(s)	342-50
P577	publication date	2002-05-01
P1433	published in	Nature Reviews Cancer	Q641657
P1476	title	Papillomaviruses and cancer: from basic studies to clinical application
P478	volume	2

Papillomaviruses and cancer: from basic studies to clinical application

scientific article (publication date: May 2002)

Reverse relations